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ABSTRACT

MECHANISMS BY WHICH APOPTOTIC MEMBRANES BECOME
SUSCEPTIBLE TO SECRETORY PHOSPHOLIPASE A2

Rachel W. Bailey
Department of Physiology & Developmental Biology
Master of Science

During apoptosis, changes occur in T-lymphocyte membranes that render
them susceptible to hydrolysis by secretory phospholipase A2 (sPLA2). To study
the relevant mechanisms, a simplified model of apoptosis using a calcium
ionophore was first applied. Kinetic and flow cytometry experiments provided
key observations regarding ionophore treatment: initial hydrolysis rate was
elevated, total reaction product was increased four-fold, and adsorption of the
enzyme to the membrane surface was unaltered. Analysis of these results
suggested that susceptibility during calcium-induced apoptosis is limited by
substrate availability rather than enzyme adsorption. Fluorescence experiments
identified three membrane alterations that might affect substrate access to the
sPLA2 active site. First, intercalation of merocyanine 540 into the membrane was
improved, suggesting increased lipid spacing. Second, laurdan detected

increased solvation of the lower head group region of the membrane. Third, the
rate at which fluorescent lipids could be removed from the membrane by albumin
was enhanced, implying greater vertical mobility of phospholipids. Thus, it was
proposed that the apoptotic membranes become susceptible to sPLA 2 through a
reduction in lipid-neighbor interactions which facilitates migration of
phospholipids into the enzyme active site.
This proposal was then examined in T-lymphocytes treated with
glucocorticoid, a more physiologically relevant apoptotic stimulant, using similar
techniques. The following observations corresponded to induction of membrane
susceptibility: increased merocyanine 540 intercalation; phosphatidylserine flipflop, detected by annexin binding; and alterations in laurdan fluorescence
properties. These observations implied a relationship among sPLA2
susceptibility, lipid spacing, and phosphatidylserine exposure. To clarify this
relationship, additional assays were also performed using dibutyryl-cAMP to
induce apoptosis, a drug reported to induce apoptosis in S49 cells without the
typical translocation of phosphatidylserine. Our results indicated that in cells
treated with dibutyryl-cAMP, the merocyanine 540 response and its correlation
with sPLA2 susceptibility was similar to that observed with dex-treated samples.
This suggests that the underlying mechanisms which promote sPLA2 hydrolysis
lead to alterations that may be facilitated by but do not require phosphatidylserine
exposure. Taken together, all of the results suggest that direct regulation of the
biophysical microenvironment of the membrane is the mode of control of
membrane susceptibility to the hydrolytic activity of sPLA2.
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INTRODUCTION
Apoptosis is a complex process involving numerous alterations to components of
the nucleus, cytoplasm and cell membrane (1, 2). Changes occurring at the cell
membrane include exposure of phosphatidylserine (PS), ceramide production,
microvesicle shedding, membrane blebbing, loss of membrane potential,
alterations to cytoskeletal attachments, and loss of membrane integrity (1-9).
One of the earliest membrane events documented thus far is a substantial
increase in the action of secretory phospholipase A2 (sPLA2) to hydrolyze plasma
membrane lipids (9, 10).
Secretory PLA2s are calcium-dependent enzymes which hydrolyze the
acyl bond in the sn-2 position of phospholipids, producing fatty acid and
lysophospholipid. This is the first reaction in the synthesis of several lipid-based
hormones. Several isoforms have been identified, each with variations in
structure, activity, and localization within the body. For example, human group
IIA sPLA2 is highly expressed in inflammatory tissues where the hydrolytic
production of arachidonic acid provides substrate for cyclooxygenase 2 and
lipoxygenase enzymes, leading to the production of proinflammatory molecules
called eicosanoids (11, 12). Human group V may function in innate immunity
(13). Elevated concentrations of human isoforms have been detected in several
pathological conditions, including sepsis, inflammation, and various cancers and
tumors (14). In these roles, sPLA2 can act both as a signal molecule and as a
hydrolytic enzyme. This study focused on the enzyme function of the protein and
how it is regulated by physical conditions in the cell membrane.
Isoforms of sPLA2 have also been isolated from other sources, including
the venoms of honeybees and snakes. This study utilized the monomeric
aspartate-49 phospholipase A2 isoform in the venom of Agkistrodon piscivorus
piscivorus (App D49). This was used as the source of enzyme in this report for
several reasons. First, it has been used extensively in previous mechanistic and
structural investigations, including studies with erythrocytes and S49 cells (9, 1526). Second, it is easily purified in large quantities making it convenient for
experiments. Third, it behaves similarly to some of the human isoforms of the
enzyme during ionomycin-stimulated apoptosis (18).
Secretory PLA2 has been used extensively for studying enzymatic activity
at the water-membrane interface. A key feature of this enzyme is its ability to
distinguish between healthy cells, which resist hydrolysis by sPLA2, and
damaged, necrotic, or apoptotic cells which are often susceptible. Studies with
artificial bilayers have demonstrated that the extent to which phospholipids are
hydrolyzed by the enzyme depends on specific physical properties and
microstructure of the membrane (17, 24-29). It has been proposed that
analogous properties also govern the susceptibility of cell membranes (19-22).
A variety of experimental approaches has led to a general concept in
which the action of sPLA2 on the membrane surface involves at least two precatalytic steps (15, 17, 23, 27, 30-32). In the first step, sPLA2 adsorbs to the
membrane surface, and in the second, an individual phospholipid migrates into
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the active site of the enzyme (Scheme 1). In previous studies, this two-step
hypothesis was examined using human erythrocytes as a simplified model for
cell membranes (22). For those investigations, the apoptotic state of the cell was
mimicked by treatment with ionomycin, a calcium ionophore. The resulting
calcium influx produced changes in membrane structure accompanied by
increased susceptibility to hydrolysis by sPLA2. Analysis of these observations
generated the conclusion that the ability of sPLA2 to attack cell membranes is
determined primarily by the ease of vertical migration of phospholipids into the
active site of adsorbed enzyme (i.e. step two in Scheme 1).
This foundational work from various membrane models has thus
generated a testable hypothesis relating bilayer structure and sPLA2 activity.
The ultimate goal is a complete understanding of the biophysical and molecular
principles governing this relationship in physiological and pathological settings
such as apoptosis. Accomplishing this goal requires experiments with nucleated
cells. Given the complexities associated with both apoptosis and cellular models
for biophysical studies, I sought an initial experimental system in which measured
effects would be synchronous and therefore maximized. Moreover, links to
previous mechanistic studies would be plausible. Accordingly, S49 murine
lymphoma cells treated with calcium ionophore (ionomycin) were chosen for the
first phase of this study because they meet these criteria. Ionomycin stimulates
rapid apoptosis that appears synchronized for the majority of the cell population
resulting in large and reproducible changes in measured events. Moreover, as
in human erythrocytes, the drug induces susceptibility to sPLA2 that, in S49 cells,
occurs with or before other major apoptotic changes (9, 18). The second phase
of this study examined S49 cells treated with glucocorticoid in order to extend
results from an artificial pharmacological agent to a more physiological stimulus.
Glucocorticoids are a class of steroid hormones that induce apoptosis in
various cell types including T-lymphocytes. Apoptotic induction occurs through
binding to the cytosolic glucocorticoid receptor (GR). The ligand-receptor
complex translocates to the nucleus where it homodimerizes and binds to
glucocorticoid response elements (GRE’s) found in promoter or enhancer regions
of various genes. It is thought that this interaction with GRE’s drives transcription
of proteins that activate apoptosis (33). While the role of the glucocorticoid-GR
complex is well established, the downstream mechanisms are somewhat
controversial and appear to vary between cell types (34); moreover, only a few
glucocorticoid-induced genes have been reliably identified, including the proapoptotic proteins Bim and PUMA (35-37). Interestingly, glucocorticoid-induced
cell death does not appear to proceed directly via either of the classical pathways
of apoptosis (i.e. the mitochondrial or intrinsic pathway and the extrinsic
pathway). Nonetheless, both Bcl-2 family proteins and caspases still seem to
play roles in glucocorticoid signal transduction (38). In addition to such
transcriptional modifications, other so-called non-genomic effects of
glucocorticoid have been observed. These non-genomic effects encompass
changes that occur too rapidly to be explained by de novo protein synthesis,
including calcium mobilization and phospholipase C activation. These effects

2

may involve a poorly defined plasma membrane GR receptor or other nonspecific interactions with cellular membranes or unrelated receptors (33, 38).
Nielson et al. characterized certain apoptotic events in S49 cells treated
with the glucocorticoid dexamethasone (dex). This investigation found that
incubating samples with dex for greater than 24 h stimulated death in nearly
100% of cells (9). Furthermore, while loss of mitochondrial membrane potential,
PS exposure, and DNA fragmentation did not change significantly until
approximately 20 h, 50% of the maximum susceptibility to sPLA2 was reached at
about 22 h (9). These results demonstrated that enhanced susceptibility is a
relatively early event in the time course of apoptosis.
In order to further elucidate the role of PS exposure in dex-stimulated
susceptibility to sPLA2 hydrolytic activity, a third apoptotic stimulus was included.
Dibutyryl cyclic AMP (db-cAMP), a lipid soluble form of cAMP, induces apoptosis
in the S49 cell line and was included in the characterization of pro-apoptotic
agents by Nielson et al. (9). According to that report, cells incubated with dbcAMP became increasingly susceptible to sPLA2 catalysis, similar to dex-treated
samples. However, very minimal PS exposure was observed with db-cAMP
treatment, suggesting that the mechanisms relating to susceptibility may be
independent of PS content in the outer membrane.
In the first phase of this study, experiments were designed to examine
each of the parameters shown in Scheme 1 to assess which is/are involved in
distinguishing resistant cells from those treated with ionophore. This assessment
was accomplished through measurements and analysis of hydrolysis kinetics,
enzyme adsorption, and membrane structure. The results demonstrated that
modulation of step two (KE in Scheme 1) accounted for the increased
susceptibility to sPLA2. Furthermore, the results in ionomycin-treated samples
identified membrane properties and possible mechanistic links between
biophysical parameters of membrane structure and vulnerability to sPLA 2
catalysis.
Accordingly, the second phase of this study consisted of assays in which
those identified properties were examined in the more physiological setting of
glucocorticoid-induced apoptosis. Part two of this study also included
experiments with a third apoptotic stimulant, db-cAMP (described above), in
order to further investigate the relationship among lipid spacing, PS flip flop, and
sPLA2 hydrolytic activity. Observations in dex-induced apoptotic membranes
found strong correlations between specific membrane properties (identified in the
ionophore-treated samples) and the onset and progression of sPLA2
susceptibility.
MATERIALS AND METHODS
Reagents
The monomeric aspartate-49 phospholipase A2 from the venom of A. p.
piscivorus was isolated according to the procedure by Maraganore et al. (39).
3

Ionomycin was purchased from Calbiochem (La Jolla, CA), cytochalasin D was
purchased from BIOMOL (Plymouth Meeting, PA), and all were dissolved in
dimethylsulfoxide (DMSO). Dibutyryl cyclic AMP (db-cAMP) was purchased from
BIOMOL and dissolved in deionized distilled water. The probes Oregon Green
488, 2-(6-(7-nitrobenz-2-oxa-1 3-diazol-4-yl)amino)hexanoyl-1-hexadecanoyl-snglycero-3 phosphocholine (NBD-PC), laurdan, acrylodan-labeled fatty acidbinding protein (ADIFAB), 1,3-Bis-(1-pyrene)propane (bis-pyrene),
diphenylhexatriene (DPH), merocyanine 540 (MC540), fluorescein
isothyocyanate-conjugated annexin V (FITC-annexin), and propidium iodide (PI)
were acquired from Invitrogen (Carlsbad, CA). Bovine serum albumin (BSA) was
purchased from Sigma (St. Louis, MO). Probes were dissolved in various
solvents as follows: ADIFAB in 50 mM KCl and 3 mM NaN3, bis-pyrene and DPH
in N,N-dimethylformamide, NBD-PC in ethanol, and all others in DMSO. Other
reagents were obtained from standard suppliers.
Cell culture and experimental protocol
S49 mouse lymphoma cells were grown at 37 °C in humidified air containing 10%
CO2 and prepared for experiments as described (16). Cell viability averaged 89
± 6% (standard deviation). For spectral and kinetic experiments, an aliquot of
cells (usually between 0.4–3.0 x 106 cells/ml in MBSS) was then transferred to a
quartz fluorometer sample cell and allowed 5 min to equilibrate in the
spectrofluorometer (Fluoromax 3, Horiba Jobin-Yvon, Edison, NJ or PC-1, ISS,
Champaign, IL). Spectral bandpass varied between 4 and 16 nm depending on
the intensity of the probe and instrument sensitivity. Data acquisition over time at
multiple wavelengths (ADIFAB, laurdan, and bis-pyrene) was accomplished by
rapid sluing of fluorometer mirrors under control of instrument software.
Temperature and sample homogeneity were maintained as described previously
for spectroscopy experiments (20). Flow cytometry samples were incubated in
shaking bath until just prior to data collection. For microscopy experiments,
sample temperature was maintained by a heated stage. Most experiments and
incubations were performed at 37 °C; some images of laurdan GP in dex-treated
samples were collected at room temperature. Classification of cells (into
categories described in Results, Part II) from these images did not vary significantly
based on temperature. For enzyme adsorption experiments, cells were
resuspended in MBSS with 20 mM BaCl2 in order to inhibit sPLA2 hydrolytic
activity without preventing adsorption (32, 40, 41).
In each procedure where ionomycin was added to cell samples (300 nM
final), the experiment was repeated with an equivalent volume of DMSO (0.25%
v/v final) added to the cuvette to control for the effects of the solvent. A control
for direct effects of ionomycin was also included in assessments of membrane
physical properties (see below). For glucocorticoid experiments, cells in culture
medium were incubated with dex (100 nM) for 0-48 h; again, each experiment
was repeated with an equivalent volume of control solvent (DMSO, 0.02% v/v)
added to the culture medium to control for effects of the solvent. For db-cAMP
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experiments, cells in culture medium were incubated with db-cAMP (100 μM) or
an equivalent volume of deionized distilled water for 18 or 30 h.
Membrane hydrolysis
Release of free fatty acids from cell membranes was assayed in real time with
the fatty acid binding protein ADIFAB (excitation, 390 nm; emission, 432 nm and
505 nm). After initiating data acquisition for 100 s, ADIFAB (65 nM final) and
ionomycin were added. At 700 s, sPLA2 (0.7 – 70 nM final) was added and the
time course continued for an additional 800 s. Raw data were quantified by
calculating the generalized polarization (GP) and fitting to an arbitrary function by
nonlinear regression (20). In some cases, hydrolysis were assayed by
measurement of the rate of PI (37 μM final) uptake by cells due to the action of
sPLA2 as described (16). Previous experiments have demonstrated that assays
with ADIFAB and PI give identical results under conditions at which cells are
susceptible to the enzyme’s catalytic activity (16). Thus, the PI assay was used
to assess hydrolysis kinetics only in experiments in which all samples were
treated with ionomycin.
Time courses of PI fluorescence were also used to assess the proportion
of the cell population susceptible to hydrolysis by sPLA2 (35 nM) in samples
treated with dex or db-cAMP (and their equivalent controls). After data
acquisition was initiated, PI, sPLA2, and ionomycin were added (with sufficient
time between each respective addition for equilibration of the fluorescence
signal). Data points between the time of PI addition and ionomycin addition were
fit to an arbitrary function by nonlinear regression that allowed quantification of
distinct populations of cells in each sample: dead cells susceptible to the enzyme
(“dead,” i.e. those that take up PI prior to enzyme addition) and live cells
susceptible to the enzyme (“alive & susceptible,” i.e. those that take up PI upon
enzyme addition). Since apoptotic cells with complete DNA fragmentation
become invisible to this assay, the maximum fluorescence signal after ionomycin
addition in the control sample was used as a measure of total cells for both the
control and the corresponding paired treatment samples. The population of cells
with complete DNA fragmentation (“DNA fragmented”) was calculated from the
difference in expected (i.e. the level reached by the control sample, standardized
for cell number as described below) and observed maximal signal after
ionomycin addition. “Total percent susceptible” was calculated by summing the
percentages of the population in the “alive & susceptible”, “dead”, and “DNA
fragmented” categories. To account for variations in cell number, data were
normalized to cell count (by light microscopy and hemocytometer) and light
scatter values separately. In most experiments both estimates of cell number
were available, and the two values were averaged to improve precision. In some
cases, only the light scatter data was collected and used.
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Fluorescence spectroscopy of probes of membrane structure
In addition to the “vehicle control” (DMSO) for ionomycin assays, a control
experiment was designed to verify that calcium entry into the cell, rather than
artifacts resulting from direct effects of ionomycin, was responsible for the
observed changes in membrane structure. This control involved incubation of
the sample for at least 200 s with the calcium chelator ethylenediaminetetraacetic
acid (EDTA; 18 mM final; the pH of the EDTA stock was adjusted to 7.6 at 37 °C
to avoid altering sample pH) prior to addition of ionomycin. In every case, the
results from this “EDTA control” were indistinguishable from those obtained with
the vehicle control. Hence, data from both types of controls are pooled in the
presentation of results in Figs. 6-9.
Emission spectra of MC540 (170 nM final) were acquired (excitation, 540
nm; emission, 550–700 nm). Spectra were obtained before the addition of the
probe, after equilibration (5 min), and 10 min following addition of ionomycin or
control reagent(s). Spectra were analyzed by subtracting the initial spectrum as
background and integrating the intensity from 565–615 nm. Effects of ionomycin
or control(s) were quantified by calculating the difference in integrated intensity
before and after treatment. That difference was divided by the integrated
intensity before treatment to account for variations in cell number and lamp
intensity. Changes in the wavelength of peak intensity were identified from
derivatives of the spectra. In samples treated with dex, db-cAMP, or their
equivalent controls, results were quantified from the integrated intensities of
spectra as the percent max response (e.g. Idex – Iionomycin / Iionomycin).
Laurdan and bis-pyrene fluorescence emission was acquired at dual
wavelengths in real time. After initiating data acquisition, laurdan (50 nM final;
excitation, 350 nm; emission 435 and 500 nm) or bis-pyrene (2.2 µM final;
excitation, 344 nm; emission 376 and 480 nm) was added at 100 s. Ionomycin or
control reagent(s) was/were included after initial equilibration of cells with the
probe (laurdan, 10 min; bis-pyrene, 30 min). The laurdan generalized
polarization (GP) and bis-pyrene excimer (480 nm)-to-monomer (376 nm) ratio
were calculated from the data as described (20, 42). Background intensity at
each wavelength was subtracted from the data prior to calculations.
Data for steady state anisotropy (DPH; excitation, 350 nm; emission, 452
nm) were acquired using Glan-Thompson polarizers in the vertical and horizontal
positions. Data were obtained before the addition of the probe to measure
background cell fluorescence, after 20 min equilibration with DPH (240 nM final),
and 10 min following addition of ionomycin or control reagent(s). Anisotropy was
calculated as described (43).
Phospholipid extraction
The fluorescent phospholipid analog, NBD-PC, was suspended in MBSS
immediately prior to experiments as described by Jensen et al. (22). Cell
samples were incubated with ionomycin, dex, or control reagent(s) (as in
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previous section) for 5 min. NBD-PC (930 nM final) was then introduced and
allowed to incorporate into cell membranes (about 30 min). Following this
incubation, cells were washed to remove excess probe. Data acquisition
(excitation, 485 nm; emission, 535 nm) was then initiated, and BSA (0.7% final)
was added for NBD-PC extraction. Apparent extraction rate constants were
obtained by fitting the fluorescence intensity data after BSA addition to a double
exponential decay function by nonlinear regression.
Cytoskeletal disruption
Cells were incubated with cytochalasin D, an actin inhibitor (10 µM final), or
control solvent (DMSO, 1% v/v), and sPLA2 susceptibility was measured with and
without ionomycin addition via the PI assay described in Results, Part II (below).
Flow cytometry
Flow cytometry data were collected from 1 ml aliquots of cells in MBSS per
sample using a BD FACSCanto flow cytometer (BD Biosciences, San Jose, CA)
with an argon laser (Oregon Green and FITC: excitation 488 nm, longpass 502
nm, bandpass filter 515-545 nm; MC540: excitation 488 nm, longpass 556 nm,
bandpass filter 564-606 nm).
Adsorption of sPLA2 to the cell surface of ionomycin-treated samples was
assayed by flow cytometry with Oregon Green 488-labeled sPLA2 (L-PLA2).
Enzyme labeling was accomplished according to instructions provided with the kit
(Invitrogen, Carlsbad, CA). Aliquots of cells (suspended in MBSS containing 20
mM BaCl2) were treated with ionomycin or DMSO for 10 min. For isotherm
experiments, varying amounts of L-PLA2 were then added (0.01 – 3 µM final),
and samples were incubated for an additional 10 min prior to data acquisition.
For competition experiments, samples were mixed with various concentrations of
sPLA2 (0.05–1 μM final) for 5 min before adding L-PLA2 (50 nM final), and the
incubation was continued an additional 5 min. Samples were then immediately
processed in the flow cytometer.
Flow cytometry measurements of MC540 and FITC-annexin fluorescence
were also made for samples treated with dex or dbcAMP. In each experiment,
samples were treated with dex, DMSO, or ionomycin prior to addition of one or
both probes. FITC-annexin labeling was done according to a modified
manufacturer protocol (Invitrogen, Carlsbad, CA) in which MBSS was used in
place of the reaction buffer provided with the probe. Samples in which MC540
was added (170 nM) were incubated in the dark in a shaking waterbath for 15
min. Samples were then immediately processed in the flow cytometer.
Two-photon excitation scanning and confocal microscopy
Scanning two-photon excitation microscopy images were obtained using an
Axiovert 35 inverted microscope (Zeiss, Thornwood, NY) at the Laboratory for
7

Fluorescence Dynamics (University of California, Irvine) as described previously
(20, 44). Laser emission was 940 nm for NBD-PC and 790 nm for Oregon Green
488. For laurdan (250 nM), dual images were collected simultaneously using a
beam-splitter and interference filters (Ealing 490 and Ealing 440) with laser
emission of 790 nm, and the laurdan concentration was increased to 250 nM to
improve image distinction compared to background. For laurdan images of dextreated samples, images of 20 randomly selected fields were collected from each
sample.
Confocal microscopy images of MC540 fluorescence were obtained using
a FluoView FV300 (Olympus, Center Valley, PA) with a green helium-neon
excitation laser (excitation 543 nm). Histograms of intensity per pixel were
obtained for confocal images. Histograms from the same experiment (i.e. from
images collected on the same day, not necessarily the same image) were then
combined into one normalized distribution of pixels such that each y value
represented the percentage of pixels in all of the combined images at each x
value. Image thresholds, contrast, and magnification were internally consistent
for all experiments displayed in Fig. 17 and included in the analysis exemplified
in Fig. 18, respectively.
Data analysis & simulations
Data plotting, statistical tests, and linear and nonlinear regression analyses were
performed with Prism GraphPad software. Simulations of flow cytometry data
were carried out using Microsoft Excel.
RESULTS, PART I: IONOPHORE-INDUCED APOPTOSIS
Hydrolysis kinetics
Addition of sPLA2 to S49 cells previously exposed (10 min) to a control vehicle
(DMSO) caused a slight increase in ADIFAB GP followed by a gradual decline,
nearly restoring the value to its original level (Fig. 1 curve a). This unusual
hydrolysis time course has been shown to represent transient initial hydrolysis
followed by re-acylation of the lipids and reincorporation into the membrane (18).
In contrast, prior exposure of cells to ionomycin resulted in a large increase in
ADIFAB GP that quickly reached a stable plateau (Fig. 1 curve b).
In order to further characterize hydrolysis kinetics, the experiment of Fig. 1
was repeated at various enzyme concentrations. Data were analyzed by
nonlinear regression (examples are shown in Fig. 1). From these
phenomenological fits, two parameters were determined: the initial rate of
hydrolysis and maximum hydrolysis product generated. As displayed in Fig. 2,
treatment of cells with ionomycin increased both initial and total hydrolysis at all
enzyme concentrations. The maximum hydrolysis rate was 0.018 ± 0.004 GP
units s-1 for DMSO-treated samples and 0.093 ± 0.011 GP units s-1 for the
ionomycin group. The enzyme concentration at which the hydrolysis rate was
one-half the maximum was 13.5 ± 7.8 nM and 9.4 ± 3.2 nM for the two groups,
8

respectively. Two-way analysis of variance indicated that both the effects of
enzyme concentration and ionomycin treatment on the initial hydrolysis rate were
highly significant (p < 0.0001). A significant interaction (p < 0.0001) between the
two variables was also observed suggesting that the magnitude of the effect of
ionomycin depended on enzyme concentration. The ability of ionomycin
treatment to increase total hydrolysis product was also significant (p < 0.0001).
Enzyme adsorption
Initial attempts to quantify adsorption of sPLA2 to the cell surface involved a
conventional centrifugation assay with fluorescently-labeled enzyme (L-PLA2) as
done previously with erythrocytes (22). However, control experiments suggested
that the observed association of enzyme with the cells was not reversible.
Analysis of microscopy images indicated that this irreversible interaction reflected
endocytosis of the labeled enzyme, a phenomenon previously described for
nucleated cells (45-47).
Flow cytometry experiments were designed to distinguish endocytosis of
labeled enzyme from reversible adsorption to the cell surface. Cells were treated
with ionomycin or DMSO for 5 min. All samples were then mixed with L-PLA2,
and half of the samples were washed to remove free enzyme. Fig. 3 displays
histograms of L-PLA2 fluorescence intensity per cell in each of these four groups.
Most of the data from DMSO-treated samples appeared to originate from a single
population of cells (Panel A). The intensity of this group was reduced ten-fold
(i.e. one log unit along the abscissa) by washing (Panel C), suggesting that this
peak represented reversible adsorption of L-PLA2 to the cell exterior. In
unwashed ionomycin-treated samples (Panel B), at least two distinct populations
were identified in the histogram of fluorescence intensity. Cells with low
fluorescence intensity (Panel B, left arrow) accounted for a majority of the sample
yet they only contributed about 20% of the total fluorescence signal. The
fluorescence of this population was also reduced ten-fold by washing, similar to
the DMSO-treated cells (Panel D, left arrow). In contrast, the high intensity
staining was less affected by washing (Panels B and D, right arrow), suggesting
that this staining represented internalization of the enzyme (45-47). This
irreversibility corroborated observations from 2-photon microscopy (not shown;
see previous paragraph). Given that reversible surface adsorption is the relevant
phenomenon for interpreting the hydrolysis kinetics, we focused our analysis on
the low intensity population.
Fig. 4 displays the amount of reversible surface adsorption of various
concentrations of L-PLA2. The average apparent equilibrium constant for
adsorption of L-PLA2 to DMSO-treated cells was 2.5×106 M-1. There was no
detectable effect of ionomycin treatment on either the apparent equilibrium
constant (1.7×106 M-1, p = 0.39) or the maximum number of adsorption sites per
cell (p = 0.20).
In order to relate these adsorption results to native sPLA2, competition
experiments were performed. Unlabeled sPLA2 competed for about 30 to 40% of
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the L-PLA2 adsorption sites at all concentrations within the range tested (0.05–1
μM sPLA2 with 50 nM L-PLA2). This result suggested that more than half of
these adsorption sites might not be relevant to hydrolysis by sPLA2. The
observation that competition was already maximal when the same concentrations
of sPLA2 and L-PLA2 were used (50 nM) indicated that the enzyme adsorbs more
tightly when it is not labeled. This inference is consistent with the relatively high
potency of the unlabeled enzyme shown in Fig. 2.
To better estimate the apparent adsorption constant for unlabeled sPLA2
(Kapp), we took advantage of control observations (not shown) demonstrating that
L-PLA2 is a weak enzyme (possessing ≤1/10 the activity of sPLA2). Accordingly,
we repeated the competition experiments using a hydrolysis assay at constant
sPLA2 concentration (70 nM final, ET in Eq. 1) in the presence of various
amounts of L-PLA2 (0.05 – 20 μM final, LT in Eq. 1). The initial hydrolysis rate
data (dP/dt) were fit to the following equation with α as an arbitrary proportionality
constant:

K app ET
dP

dt 1  K app ET  K L LT

(1)

We assumed that KL, the adsorption constant for L-PLA2, was the same at
sites of hydrolysis as that estimated for the entire cell in Fig. 4. Results shown in
Fig. 5 provide convincing evidence for competition. Analysis of the data by
nonlinear regression estimated that Kapp equals 2.7×107 M-1.
Physical changes in the cell membrane
Previous experiments with erythrocytes revealed several physical changes in the
cell membrane that appeared to explain the basis for increased susceptibility to
the action of sPLA2. These included increases in the spacing among bilayer
lipids, the average level of lipid order, and the rate at which fluorescent
phospholipids could be extracted from the cell membrane (22). Similar
experiments have been included here to test the relevance of those findings to
nucleated cells.
Phospholipid spacing
Changes in phospholipid spacing were assessed with MC540, a probe that
intercalates between the phospholipid heads in the outer leaflet of cell
membranes (48-50). Treatment of cells with ionomycin resulted in a significant
increase in MC540 total fluorescence (Fig. 6A) and a red-shift in peak
wavelength from about 583 to 586 nm (Panel B) consistent with increased
binding of the probe (51). As shown in Panels C and D, these effects were
reproducible. Control experiments in which cells were treated with ionomycin in
the presence of a calcium chelator (EDTA) demonstrated that these effects were
due to calcium influx rather than representing artifacts caused directly by the
presence of ionomycin in the membrane. Since EDTA controls were
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indistinguishable from DMSO-treated samples, data from both types of controls
were pooled in the presentation of results for MC540 and all other probes of
membrane physical properties (see legends to Figs. 6-9). These spectral
changes in MC540 fluorescence suggested that treatment with ionomycin
increased the spacing among membrane phospholipids.
Membrane order
Three fluorescent probes were used to examine the relationship between
susceptibility and membrane order. Laurdan intercalates at the level of the
glycerol backbones (52). The shape of laurdan’s emission spectrum is highly
sensitive to the solvent relaxation effect and is quantified as GP (see Materials
and Methods). GP varies between -1.0 and 1.0 and has been interpreted to
reflect the degree to which lipid molecules are ordered within the membrane (a
value of 1.0 denotes a highly ordered membrane in which no solvent relaxation
occurs, Ref. 42, 43). Bis-pyrene has traditionally been used to evaluate the level
of “fluidity” in the membrane, implying the ability of molecules to diffuse laterally
along the bilayer plane (53). More recent experiments exploring the
phosphatidylcholine/cholesterol phase diagram indicated that the probe is more
sensitive to phospholipid acyl chain order (54). Presumably, bis-pyrene resides
deep in the membrane based on the partitioning of the parent compound, pyrene
(55). Diphenylhexatriene also locates deep in the membrane (56). The
anisotropy of DPH is sensitive to both fluidity (which alters the rotational diffusion
rate of the probe) and environmental constraints imposed by the level of chain
order (54, 57).
Laurdan GP before and after treatment with ionomycin and subsequent
controls are illustrated in Fig. 7. In Panel A, laurdan GP over time is displayed.
Ionomycin (added at arrow) caused GP values to decrease until reaching a
minimum 10 min after treatment. This effect was significant (Panel B). Images
collected by two-photon microscopy verified that the changes reported in Fig. 7B
were confined to the plasma membrane (Figs. 7C–F). In contrast, no differences
in apparent lipid order were identified with either bis-pyrene excimer-to-monomer
ratio or DPH steady state anisotropy (Fig. 8).
Phospholipid extractability
Changes in the propensity of phospholipids to migrate vertically in the bilayer
were estimated by extraction experiments utilizing NBD-PC, a fluorescent
phospholipid analog that inserts into lipid bilayers (22, 58). We used the protein
BSA as a lipid acceptor in these experiments. This protocol allowed us to
estimate the rate of extraction. As shown in Fig. 9A, time courses of NBD-PC
fluorescence following BSA addition were fit to a two-phase exponential decay
(with t=0 corresponding to the time of BSA addition), with a rapid initial drop in
intensity followed by a gradual decline. An overall rate constant was derived
from the regressions and compared for multiple samples (Fig. 9B). Ionophore
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treatment generated a reproducible two-fold increase in the rate of NBD-PC
extraction.
Initial and final fluorescence intensities often differed between DMSO- and
ionomycin-treated samples (generally greater in the ionophore group, not
shown). For this reason, the data in Fig. 9A are normalized. We used flow
cytometry and two-photon microscopy to address the possibility that intensity
differences reflected artifacts (due to the extent of extraction and/or labeling) that
might interfere with our analysis. Flow cytometry experiments demonstrated that
the amount of fluorophore removed by BSA was comparable between control
and treatment groups (89% and 85% respectively, not shown). Two-photon
microscopy images revealed that it was common for cells to display labeling of
internal compartments in addition to the plasma membrane (more prominent in
ionomycin-treated cells; example shown in Figs. 9C–E). Upon BSA addition
(between Panels C and D), fluorescence intensity decreased quickly from the
perimeter of the cells and more gradually from the interior (Panel D: 2 min after
addition, Panel E: 4 min after addition). These experiments convinced us that at
least the initial rapid decay of fluorescence intensity, dominant in the analysis
shown in Figs. 9A and B, could reasonably be interpreted to represent lipid
extraction from the cell membrane.
Cytoskeletal disruption
The drug cytochalasin D was employed to elucidate the role of the actin
cytoskeletal network in determining susceptibility to sPLA2 catalysis. Cytochalsin
D is a cell-permeable drug that binds to the barbed end of actin filaments, inhibits
both the association and dissociation of subunits, and thus disrupts actin
filaments and inhibits actin polymerization (59-61). Cells were incubated for 1560 min with cytochalasin D or control solvent, and sPLA2 hydrolytic activity was
assessed via the PI assay (see Materials and Methods). Cytochalasin D
exposure did not affect the proportion of the population susceptible to the
enzyme (Fig. 10, p = 0.34). Analysis of the effect of cytochalasin D treatment on
the kinetics of PI fluorescence changes upon ionophore addition showed mixed
results. While the maximum rate of PI uptake in the presence of sPLA 2 and
ionomycin was greater in cytochalasin D treated-samples (data not shown, p =
0.02), the half-time of ionomycin response was unchanged by the actin inhibitor
(Fig. 10, p = 0.55). Interestingly, long incubations with cytochalasin D (i.e. long
enough for the drug to induce apoptosis, Ref. 62) did not show increased proportion
of cells susceptible to sPLA2 (data not shown). Furthermore, assays of MC540
fluorescence spectroscopy confirmed that cytochalasin D treatment did not
increase MC540 fluorescence intensity (data not shown, p = 0.48, n = 6, 3
treatment and 3 control). These results suggested that inhibition of f-actin by
cytochalasin D did not significantly affect lipid spacing or the interaction between
the membrane surface and sPLA2, even in the presence of ionomycin.
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DISCUSSION, PART I: IONOPHORE-INDUCED APOPTOSIS
The goal of this portion of the study was to identify how changes in the cell
membrane induced by calcium ionophore treatment might increase the rate of
phospholipid hydrolysis by extracellular sPLA2. To this end, the model shown in
Scheme 1 was used to analyze the results of the kinetic experiments displayed in
Fig. 2. The initial rate of lipid catalysis (dP/dt) is given by

 K A ET K E S T
dP

dt 1  K A ET (1  K E S T )

(2)

where β is proportional to kcat and the total number of adsorption sites for the
enzyme (ET) (22). It is assumed that β does not change with experimental
treatment because alterations to membrane structure would presumably affect
reaction steps preceding the catalytic event (see Ref. 22 and discussion below).
For simplicity, β is assigned a value of 1.0 GP units s-1. ST represents the mole
fraction of membrane phospholipids available to the enzyme. In previous
analyses, it has not been considered separately from KE since the two
parameters are completely linked in the model (see Eq. 2 and Ref. 22).
However, the data of Fig. 2B demonstrate that ST is subject to change upon
experimental treatment and provide information to quantify the magnitude of that
change. ST is therefore included specifically as a parameter in Eq. 2 and
expressed in relative units (i.e. it is assigned a value of 1.0 under control
conditions).
As shown in Fig. 11A, the control data from Fig. 2A were well fit by Eq. 2.
The value of KA (6.7 × 107 M-1) matched favorably the value estimated from
competition with L-PLA2 (2.7 × 107 M-1 in Fig. 5). The effect of ionomycin on the
initial hydrolysis rate was evaluated by considering ST, KA, and KE individually in
the fit in order to identify the minimum criteria required by the results (parameter
values summarized in Table 1). The data of Fig. 2B indicated that ST increased
by a factor of about 4.4 with ionophore treatment. Accordingly, Eq. 2 was recalculated maintaining all parameter values from the fit of the control data with
the exception of ST. The 4.4-fold increase, however, was insufficient to account
for the ionomycin data (Fig. 11B). In fact, a reasonable fit was obtained only with
a much larger (8.1-fold) increase in ST, one that cannot be justified based on the
data of Fig. 2B (Fig. 11C). Since KE and ST are linked in Eq. 2, the dilemma can
obviously be resolved by increasing KE by a factor of 1.8 in addition to a fixed
4.4-fold increase in ST (Fig. 11D). Alternatively, allowing KA to vary instead of KE
was inadequate to accommodate the data (Fig. 11E). The best fit, of course,
was obtained when both KA and KE were allowed to float in combination with the
prescribed increase in ST (Fig. 11F). This ideal fit corresponded to a 2-fold
increase in KE (in strong agreement with that of Panel D) coupled with a
reduction in KA by about 16% (corroborating the result in Panel E). Thus, I
concluded from this analysis that increased susceptibility following ionomycin
treatment has little or nothing to do with the strength of adsorption (KA) and can
be explained entirely by increases in the accessibility of lipids to the enzyme
active site (KE and ST).
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It is important to note that the differences between control and treatment
curves in Fig. 2A could easily be explained by adjustments to kcat. Variations in
kcat could be due to either cofactor availability or enzyme conformational change.
Since the same medium was used in all data sets, availability of the cofactor
calcium was not an issue. Moreover, if changes in membrane microstructure
stabilized the transition to an activated enzyme conformation, that stabilization
would be reflected by enhanced adsorption of sPLA2 to the membrane surface.
While multiple conformations of sPLA2 have indeed been observed and may be
linked to adsorption and/or substrate binding (63), I have no evidence that
adsorption of the enzyme is altered by ionomycin. Therefore, it is unlikely that
conformational transitions are affected by ionophore treatment, and the use of a
constant value for kcat (i.e. the parameter “β” in Table 1 and Eq. 2) is appropriate.
It may seem surprising that the affinity of the enzyme to adsorb to the
membrane surface (KA) was not altered by ionomycin treatment (Fig. 4). It is well
established that calcium influx promotes exposure of anionic PS on the outer
surface of the cell membrane (64, 65). In previous studies with ionophoretreated S49 cells, this lipid flip-flop occurred as early as could be detected and
corresponded temporally with increased susceptibility to sPLA2 activity (9).
Moreover, the presence of anionic lipids greatly promotes sPLA2 adsorption in
artificial bilayers and some cell types (17, 66-68). Since much of the adsorption
of L-PLA2 observed in Fig. 4 appeared unrelated to membrane hydrolysis (for
example, binding to heparin sulfate, Ref. 69), it could be argued that the methods
employed to assess KA were incapable of discerning relevant changes. For this
reason, we applied the kinetic analysis detailed in Fig. 11, which substantiated
the idea that differential membrane susceptibility is not determined by variation in
enzyme adsorption. Furthermore, experiments in human erythrocytes with an
inhibitor of PS translocation supported the conclusion that exposure of anionic
lipids was not a requirement for enhanced hydrolysis upon ionomycin treatment
(9, 19). This view is supported by studies which indicate that apoptotic stimuli
other than ionomycin induced sPLA2 susceptibility prior to PS exposure in S49
cells (9). Overall, these findings suggest that transbilayer movement of specific
phospholipids does not necessarily provide a preferred substrate for the enzyme,
nor is flip-flop the primary determinant of membrane vulnerability to sPLA2.
Nonetheless, loss of membrane asymmetry could possibly alter other properties
of the phospholipid bilayer which then render the membrane sensitive to sPLA 2
activity. For example, exposure of PS could contribute to the increased lipid
spacing I observed (70).
A caveat to the conclusion that increased membrane susceptibility to
sPLA2 does not result from enhanced enzyme adsorption and/or flip-flop of PS is
the fact that the experiments reported here were conducted with enzyme purified
from snake venom. Several isoforms of sPLA2 have been identified which differ
in their intrinsic catalytic activity (kcat), their affinity for membrane surfaces, and
their dependence on the presence of anionic lipids (71). Thus, the degree to
which PS exposure and potential differences in KA contribute to the level of
membrane hydrolysis under different experimental or physiological conditions
may well depend on the isoform in question. Nevertheless, previous experiments
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with human groups IIa and V sPLA2 species displayed behavior toward S49 cells
that was qualitatively identical to that observed with the snake venom enzyme
(18). Therefore, although quantitative differences exist among various sPLA 2
types, the concept that substrate availability contributes, at least in part, to the
level of membrane susceptibility probably applies to all of them.
Structural evidence suggests that sPLA2 acts at the membrane surface
with its active site displaced physically from the position normally occupied by
bilayer phospholipids (31). If this is true, substrate availability (ST) represents the
number of lipids capable of making a vertical movement from their normal
position, which, according to the results (Fig. 2B), increases during a sustained
calcium influx. Moreover, the larger value of KE required to fit the data indicated
that this vertical transition also occurred more easily.
I focused my analysis primarily on the initial rate of hydrolysis to avoid
concerns about latent hydrolysis of internal bilayers such as the perinuclear
membrane (46, 47). Of course, measurement of total hydrolysis would include
any internal hydrolysis product generated during the 10 min time frame of the
experiment (see Fig. 2B), especially with ionomycin treatment which promoted
internalization of L-PLA2 (see Fig. 3B). Therefore, it may be unreasonable to
include the full measured value of ST in the analysis with Eq. 2. The observation
that the majority of total hydrolysis to be accomplished is complete within about
50 s (Fig. 1) mitigates this concern since this time scale is shorter than that
reported for internalization (46, 47). Based on the linkage of KE and ST in Eq. 2,
overestimation of ST corresponds to underestimation of KE; thus, changes in KE
may be greater than was assumed in the analysis detailed in Fig. 11 and Table 1.
Regardless of the relative contributions of those two parameters to the effect of
ionomycin on the initial rate, the argument that the membrane properties have
changed to facilitate availability of substrate (either kinetically, KE, or physically,
ST) to the active site of the enzyme is still valid. Obviously, the mechanistic basis
for increased ST in the presence of ionomycin requires additional investigation.
What could account for the increase in substrate access to the enzyme?
The fluorescence of three of the five membrane probes we examined changed
reproducibly due to ionophore. For example, MC540 bound more easily to the
membrane, and laurdan emission was red-shifted consistent with increased
penetration of water molecules into the bilayer. These two observations suggest
that the membrane surface had become more accommodating to intercalation of
contaminating molecules from the aqueous phase. This result, together with an
enhanced rate of NBD-PC extraction from the outer leaflet of the cell membrane,
implied that the strength of interaction among neighboring phospholipids was
diminished by calcium influx. With the loss of favorable interactions coupled with
increased hydration of the bilayer, the hydrophobic active site of the enzyme
would presumably become a more attractive alternative to the membrane thus
enhancing the probability of hydrolysis.
Another possible explanation for the laurdan fluorescence relates to
phospholipid chain dynamics. Many studies have suggested that changes in
solvent access to laurdan correlate with the level of phospholipid chain order (42,
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43, 72-74). The experiments conducted with bis-pyrene and DPH allowed me to
examine whether such was the case here since both probes are sensitive to the
order of their environment (54). Interestingly, neither probe detected any change
associated with ionomycin treatment. Therefore, the average level of
phospholipid chain order in the membrane appeared to remain stable during
calcium influx, and my interpretation of laurdan fluorescence relating to hydration
changes at the membrane surface appears more plausible.
Initially, it may seem counterintuitive to propose that disruptive alterations
occurred that were detected readily at the membrane surface without removing
constraints on probe motion deep in the bilayer. One possibility is that ionophore
treatment generated local regions of high curvature stress in the membrane
causing an increase in head group spacing simultaneous with crowding of the
chains. Since phospholipid micelles are excellent substrates for sPLA2 (75),
such local curvature could explain the various observations in this report. I also
note that changes in lipid spacing can occur without accompanying alterations in
lipid order and/or lipid fluidity within liquid-ordered phases in both erythrocytes
and artificial membranes (54).
This result (alterations at the surface with no change in chain order)
contrasts observations from erythrocytes in which treatment with ionomycin
actually increased the average lipid order of the membrane (19-21). Two
distinctions between erythrocytes and lymphocytes are helpful in understanding
this difference. First, susceptibility to hydrolysis upon ionophore treatment is
about six times greater in lymphocytes than in erythrocytes (comparison of data
in Fig. 2 to Ref. 19). Logically, one would expect that membrane changes
relevant to hydrolysis would also be more prominent in S49 cells. Changes
observed in laurdan GP and MC540 fluorescence intensity were enhanced by
factors of about 10 (in the opposite direction) and 70, respectively, fulfilling this
criterion (comparison of data in this report with raw data used in Ref. 21, 22).
Second, microscopic images of erythrocytes revealed that ionomycin-induced
alterations in lipid order were confined to specific membrane domains (19, 21).
In general, membrane domains in nucleated cells are much smaller than those of
erythrocytes (76), making it unlikely that similar observations of increased order
in discrete domains would be possible in lymphocytes, especially against the
background of a more pronounced membrane hydration described above.
Nevertheless, it is important to note that the data described for erythrocytes led
to the same conclusion as that inferred here: that increased susceptibility to
enzyme hydrolysis is precipitated by a reduction in the strength of lipid-neighbor
interactions.
A major remaining question is the means by which ionophore treatment
produces membrane changes responsible for elevated sPLA2 activity.
Resolution of this matter will require genetic and biochemical approaches beyond
the scope of this study. Nevertheless, possible candidates may be identified
from existing reports. The fact that cells rapidly become susceptible to sPLA 2
(i.e. within 10 min) during ionomycin-induced apoptosis helps evaluate the
possibilities and exclude those events that arise too late (9). One obvious
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candidate for linking known apoptotic events with membrane sensitivity to sPLA 2
is the exposure of PS. As discussed above, this event appears unable to explain
the increase in membrane hydrolysis, at least for the snake venom enzyme.
Membrane blebbing and loss of integrity can also be eliminated as major
contributing factors because these events occur much later than the onset of
susceptibility (9). The images in Figs. 7 and 9 corroborate the observation with
respect to blebbing. The sustained loss of membrane potential associated with
ionophore and hormone-induced apoptosis in lymphocytes also appears to occur
on a time scale well beyond that relevant to the phospholipase (3, 5).
Ceramide accumulation, through de novo synthesis and cleavage of
sphingomyelin, is well established as a participant in apoptotic signaling
pathways (2). Furthermore, it has been suggested that sphingomyelin inhibits
sPLA2, and that its removal could therefore promote increased activity of the
enzyme (77, 78). The details of ceramide’s role in apoptosis vary among cell
types (2) and have not yet been characterized in S49 cells. Nonetheless, in prior
experiments, treatment of S49 cells with sphingomyelinase did not enhance
sPLA2 activity (18).
In addition to blebbing, apoptotic cells sometimes shed smaller pieces of
the plasma membrane known as microvesicles. Such is the case with
ionomycin-stimulated S49 cells (18). This microvesiculation appears to be
facilitated by both PS exposure and cytoskeletal cleavage, and the vesicles
released are susceptible to the enzyme (19, 77, 79-82). These observations
raise the question of whether the increase in membrane susceptibility reflects
direct hydrolysis of the plasma membrane or instead degradation of released
microvesicles. This issue has been addressed extensively in studies of human
erythrocytes and S49 cells. In both cases, the conclusion was reached that while
microvesicles are attacked by the enzyme, they represent a minor fraction of the
total hydrolysis with the remainder representing membranes associated with the
cells (18, 19).
Cytoskeletal alterations are more likely candidates for apoptotic events
that might alter the membrane’s response to sPLA2 (6-8). Given the sensitivity of
various membrane properties to cytoskeletal structure during apoptosis (6), it is
reasonable to speculate that the same may be true for the response to sPLA 2.
For example, membrane tension could be highly important in determining the
access of lipids to the enzyme active site (30) and certainly would be affected by
the arrangement and number of cytoskeletal attachments. Likewise, cytoskeletal
elements may regulate the lateral distribution of membrane lipids. Disruption of
domain structure upon cytoskeletal rearrangement could free additional substrate
for catalysis that previously was inaccessible to the enzyme (thus, the increase in
ST). Furthermore, cytoskeletal disruption itself can induce apoptosis in
thymocytes (62). However, as shown in Fig. 10, short incubations with
cytochalasin D did not induce sPLA2 susceptibility. This suggested that
disruption of the actin network alone in S49 cells was not sufficient to render
membranes vulnerable to sPLA2 catalysis. Moreover, cytochalasin D treatment
did not accelerate the action of ionomycin. This result implied that, even if actin
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disruption is a part of the mechanism whereby ionophore induces susceptibility to
the enzyme, it is not the rate limiting step. This does not, however, rule out
possible involvement of actin filaments or other cytoskeletal elements in the
conversion of cells from resistant to susceptible during the progression of
apoptosis. The role of cytoskeletal attachments and dynamics in membrane
integrity and resistance to sPLA2 requires further investigation.
In summary, the results from Part I strongly suggested that membrane
hydrolysis by snake venom sPLA2 is promoted by increased lipid spacing, water
penetration into the bilayer, and diminished inter-lipid interactions during
ionophore-stimulated apoptosis. These changes appear to enhance hydrolysis
by facilitating phospholipid entry into the enzyme’s active site rather than by
increasing enzyme adsorption to the membrane surface. These observations
raised several questions. How do the results for the snake venom enzyme apply
to the various human isoforms of sPLA2? Are the results relevant to other, more
physiological, inducers of apoptosis? What is the temporal relationship among
these membrane physical changes, susceptibility to sPLA2, and known
membrane events during apoptosis, such as the exposure of PS? The first
question is beyond the scope of this thesis, but the other two were addressed by
studying glucocorticoid- and cAMP-provoked apoptosis.
RESULTS, PART II: GLUCOCORTICOID & DIBUTYRYL CYCLIC AMPINDUCED APOPTOSIS
Time course of sPLA2 susceptibility
In order to quantify susceptibility on a percentage basis, a control was developed
to identify the maximum level of susceptibility for each sample. Susceptibility
was measured using a time course of PI fluorescence in cells pre-treated with
dex or DMSO (see Materials and Methods, exemplified in Fig. 12A). Propidium
iodide was added at arrow 1, and sPLA2 was added after equilibration with the
probe (arrow 2). Once the fluorescence signal stabilized after enzyme addition,
ionomycin was added (arrow 3). The purpose of adding ionomycin was to render
any resistant cells remaining in the population susceptible, providing a measure
of maximal PI fluorescence intensity that corresponded to 100% of cells staining
with the dye. The ability of ionomycin to induce maximal susceptibility was
confirmed by repeating the assay with detergent added after ionomycin (data not
shown). Percentages of the cell population susceptible or resistant to the
enzyme were calculated from each PI time course (see Materials and Methods
for details). Fig. 12B illustrates the progression of total susceptibility as a
function of percent of cells dead (measured by trypan blue uptake) fit to a
sigmoid function by nonlinear regression (midpoint = 45.42% dead ± 3.12%; see
Table 3). The sigmoidal relationship between susceptibility and apoptotic cell
death reported here agrees with previous observations (9).
Measurement of cell death by trypan blue uptake is more useful for
calibrating progress through apoptosis than length of incubation with dex due to
intersample variability with respect to the kinetics of the apoptotic response. This
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is likely due to asynchronous cell cycling, cell density, and other factors.
Therefore, “percent dead” is used in place of “time of incubation” in the display of
data throughout the results in Part II. Corresponding measurements of PI
fluorescence were obtained for each of the samples included in Figs. 13-16, 18,
25 in order to directly compare physical changes in the membrane and
susceptibility to sPLA2 during glucocorticoid- and dbcAMP-stimulated apoptosis.
Physical changes in the cell membrane
Phospholipid extractability
To determine whether alterations in phospholipid-neighbor interactions were
present and contributing to the onset of susceptibility, extraction experiments with
NBD-labeled lipids were repeated in dex-treated samples (see Results, Part I for
explanation of protocol). The results suggested a trend between dex-induced
cell death and NBD-PC extraction rate constant, consistent with observations in
ionophore-treated samples (Fig. 13). However, the apparent trend was not
significant based on linear regression (p = 0.19, r2 = 0.26, n = 8). This difficulty in
measuring reproducible changes in extraction rate was not surprising since the
effect was already small under optimal experimental conditions (i.e. during
synchronous apoptosis initiated by ionomycin, Fig. 9). Hence, one would
anticipate that the effect would be smaller and therefore harder to detect in the
heterogeneous mixture intrinsic to dex treatment.
Water penetration
DPH and bis-pyrene experiments did not detect any changes in the membrane
interior during ionomycin-induced apoptosis (Fig. 8). Accordingly, laurdan was
the only probe of membrane interior that was used to assess the membrane
during dex-induced cell death. Initial attempts to monitor laurdan GP by
spectroscopy detected no changes in dex-treated samples (data not shown).
There are several possible explanations for this observation: there may be no
changes during dex-stimulated apoptosis, changes could be very subtle, cells at
different points along the apoptotic continuum probably coexist in the same
sample, and/or changes in laurdan GP may sequentially change in more than
one direction from the initial level.
To explore these possibilities, the spatial distribution of laurdan GP values
in dex-treated cell membranes was visualized by two-photon excitation
microscopy. This approach allowed laurdan GP to be calculated for individual
cells and not averaged for entire samples as in the cuvette. Twenty images were
collected for each experiment in order to obtain a representative sample. During
the collection and analysis of these images, one major observation was made.
Cells could be classified into three distinct categories based on the pattern of GP
values across the surface of the cell: “ring,” “mixed,” and “red”. The divisions
among categories were evident both through GP values (of the whole cell and
the interior) and visual sorting. The numerical distinctions for each category are
19

summarized in Table 2. Examples of the three categories are displayed in Figs.
14A-D. The cell populations were initially composed mostly of “ring” cells with
few “mixed” or “red”. As apoptosis progressed to about 40% dead, there was a
rise in “mixed” cells concurrent with a reduction in the proportion of “ring”.
Finally, once the population reached 75% dead, “mixed” and “ring” cells both
decreased, and “red” became the dominant pattern (displayed in Panel E). This
progression suggested that cells start in the “ring” configuration, progress
through the “mixed” intermediate, and end in the “red” configuration. The timing
of the appearance of “mixed” cells corresponded to the appearance of the “alive
& susceptible” population, as illustrated in Panel F.
Phospholipid spacing
Spectroscopic measurements of MC540 fluorescence were obtained to
determine whether changes in lipid spacing corresponded with the timing of
susceptibility in dex-stimulated apoptosis. Similar to the PI assay (described
above), spectra were obtained on each control/treatment sample before and 10
min after ionomycin addition in order to compare dex-induced spectral changes
to the maximal response. Fig. 15 displays the results of these experiments.
Panel A shows a representative set of spectra from a control sample (black
dashed curve), a corresponding sample treated with dex for 24 h (black solid
curve), and the dex sample after additional incubation with ionomycin for 10 min
(red curve). These results were quantified as the percent of maximal response
(described in Materials and Methods) and scaled to the complete range of values
for the data set (∆/∆max). As shown in Panel B, the change in MC540 intensity
corresponded to the onset of sPLA2 activity. This correlation was confirmed by
linear regression between ∆/∆max and total percent susceptible (p < 0.0001, r2 =
0.57, n = 68; 35 treatment samples and 33 control samples). Furthermore, the
midpoint of the sigmoid fit of ∆/∆max was 46.98% dead ± 6.53%. Since this range
overlaps the 95% confidence interval for the total percent susceptible midpoint
value, these two processes are statistically indistinguishable (see Table 3).
MC540 fluorescence was also quantified for individual cells using flow
cytometry. Examples of histograms of the flow cytometry data are shown in
Fig.19A. These histograms were analyzed by two different methods. First, the
mean fluorescence intensity (denoted by the abscissa) was normalized to the
maximum mean and graphed as a function of percent dead. Second, a
normalized ratio was obtained for each histogram. This ratio was calculated by
counting the number of cells in the “response” peak (high intensity fluorescence,
region 2 in Panel A) and dividing by the number of cells in the “background” peak
(low intensity fluorescence centered around zero, region 1 in Panel A). Unlike
the mean, the histogram ratio is independent of fluorescence intensity; it depends
only upon the proportion of cells that have migrated from the background to the
response peak. Therefore, these two analysis methods (histogram mean and
cell ratio) capture different aspects of MC540 fluorescence in the cell population.
As demonstrated in Fig. 16A, the mean of the histogram varied sigmoidally with
respect to percent of cells dead. More importantly, the midpoint of this fit
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(44.41% dead ± 5.45%) was statistically indistinguishable from those of both
MC540 ∆/∆max (Fig. 15) and total percent of cells susceptible to sPLA2 (see Table
3). This observation suggested that spectroscopic ∆/∆max and mean intensity
from the flow cytometry assessments corresponded to each other and reflected
the same membrane properties. On the other hand, the second analysis method
of flow cytometry data, the histogram cell ratio, did not correspond to these other
two measures of MC540 fluorescence. While its relationship to percent dead
also appeared to be sigmoidal (Figs. 16B, 19C), the midpoint was delayed to
64.19% dead ± 5.39%, a statistically robust offset of approximately 20% on the
abscissa compared to the other two measures of MC540 response (see Table 3).
This intriguing result implies that the two analyses of the flow cytometry data are
revealing separate aspects of the membrane properties detected by MC540
during dex-stimulated apoptosis. The nonlinear regression fits for the histogram
mean, the cell ratio, and the ∆/∆max are overlaid together with the total percent
dead in Fig. 16C to visually display these relationships. The midpoints and
confidence intervals from these sigmoid fits are also summarized in Table 3.
Images of MC540 fluorescence were also obtained by confocal
microscopy. The purpose of these experiments was two-fold: to verify that
MC540 was reporting changes in the plasma membrane and not internal
compartments and to assess changes in the proportion of high-intensity pixels in
the labeled cell membrane in response to apoptotic stimuli. With respect to the
first objective, MC540 fluorescence appeared to be well confined to the
membrane in control samples. There was some internal staining of cells with the
probe at longer incubations with dex (e.g. 48 h), although these caused little
concern since the focus was on events during the first half of the apoptosis time
course. Staining of intracellular membranes also increased during long
incubations with ionomycin (i.e. greater than 15 min). However, internal staining
at only 10 min after ionomycin did not appear to be responsible for spectroscopic
results. Furthermore, it was difficult to distinguish internal labeling from changes
in the volume and shape of cells and apoptotic bodies in samples which are
approaching the endpoint of apoptosis. Example images are displayed in Fig.
17.
The proportion of high intensity pixels was first assessed in ionomycintreated samples. Normalized pixel values were obtained from histograms of
confocal images as described (see Materials and Methods) and plotted as a
function of intensity. As shown in Fig. 18, the proportion of low intensity pixels
decreased after 5-10 min incubation with ionophore (seen in the reduction in the
peak indicated by arrow 1 in the red data points compared to the gray data
points). By default, the decrease in the low intensity peak indicated that those
pixels had redistributed to higher intensities (since the area under each curve
equals 100%). To statistically assess this redistribution, two analyses were
performed. First, histograms of pixel distributions from individual experiments
were fit by nonlinear regression to an arbitrary function with fitting parameters
that correspond to the maximum y value (i.e. the low intensity peak, indicated by
arrow 1) and the pixel percentage at an intensity value of 2000 (considered the
lower boundary of the “higher intensity” region, indicated by arrow 2). The ratio
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of these two parameters (i.e. (ordinate value at arrow 1) / (ordinate value at arrow
2)) was calculated for each of the samples exemplified in Fig. 18, before and
after ionomycin ratios were compared by unpaired Student’s t-test (p = 0.029, n =
6). In the second analysis, the histograms of pixels before and after ionomycin
were gated into four bins based on the intensity (i.e. 0-1000, 1001-2000, 20013000, and 3001-4100). The pixel percentages before and after ionomycin were
then compared in each of those four regions by one-way analysis of variance,
which found a significant difference in the percentage of pixels in each bin (p <
0.0001) and, more meaningfully, a significant interaction between ionomycin
treatment and percentage of pixels in each bin (p = 0.0071, n = 6, no matching).
This corroborated the first analysis in finding a significant redistribution of pixels
from lower to higher intensity levels in apoptotic membranes. This second
analysis was repeated in cells treated with dex or DMSO. However, dex samples
did not show a redistribution of pixels towards higher intensity values compared
to control cells. This may be due to the lack of before-after measurement of the
same cell sample as well as to the asynchronous onset of apoptosis in response
to dex.
PS exposure
Transbilayer movement of PS to the outer leaflet was evaluated by flow
cytometry. Cells treated with dex or DMSO were mixed with FITC-annexin, a
fluorescently labeled protein which binds to exposed PS (83). Histograms of
FITC-annexin fluorescence were analyzed by the same two methods as the
MC540 histograms (described above), and example histograms are displayed in
Fig. 19B. An interesting phenomenon was observed in the histograms of FITCannexin over time of dex incubation. At time points of about 24 h (corresponding
to roughly 50% of cells dead), the response peak obtained a maximal intensity
(i.e. the abscissa value of region 3 in Panel B). However, at longer time points,
the maximal intensity receded toward the background peak (i.e. region 2 in Panel
B). After further inspection, it appeared that this progression and regression was
simply due to limited probe as the number of PS binding sites continued to
increase. Since probe became limiting, the mean intensity of the histograms is
likely not an accurate measure of phospholipid asymmetry during apoptosis,
especially towards the end of the apoptosis time course in cell samples.
Therefore, only the histogram ratio of FITC-annexin fluorescence intensity was
included in the presentation of data and comparisons.
Relationship between PS exposure and MC540 fluorescence
Dex treatment
The relationship between PS exposure and MC540 fluorescence in response to
dex treatment was examined with various analyses. First, the histogram ratios of
MC540 and FITC-annexin fluorescence (from flow cytometry data, described
above) were found to correlate very strongly, quantified by linear regression (data
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not shown; p < 0.0001, r2 = 0.93, n = 31 treatment samples and 30 controls).
The sample size reflected 61 matched pairs in which both probes were added
either simultaneously to the same tube or to separate tubes from the same cell
culture and incubated parallel to one another. The comparability between the
sigmoid fits of the histogram ratios of FITC-annexin and MC540 fluorescence is
illustrated by virtually identical midpoints (see Fig. 19C and the last two lines of
Table 3). Furthermore, the histogram ratios of MC540 and FITC-annexin
displayed relationships that both lagged behind the curve of total percent of cells
susceptible to sPLA2, as shown in Fig. 19C.
An additional analysis was performed for those samples in which the
fluorescence of both probes was assessed simultaneously in cells labeled with
MC540 and FITC-annexin. Two-dimensional histograms of the fluorescence
from both probes in each cell were plotted and analyzed by linear regression. An
example plot with the accompanying linear regression is displayed in Fig. 20A. I
found a distinct, nonsymmetrical pattern in the residuals from these linear
regressions, exemplified in Panel B. This pattern involved a right-skewed peak
above the x-axis and a gradual decreasing slope in the shape of the values
below the x-axis.
In order to interpret this pattern in terms of a temporal displacement
between MC540 and FITC-annexin fluorescence, simple data simulations were
performed in Excel. These simulations generated data for 10,000 cells over the
course of apoptosis (simulated by a sigmoid function, verified by data in Figs. 12,
15, 16, and 19) and were analyzed by linear regression to create residual plots.
Simulated residual plots were produced for three different situations: one in
which the sigmoid midpoint parameter was shared for both probes (i.e. no
temporal offset, Fig. 21), a second in which the midpoint for MC540 binding
narrowly preceded that of FITC-annexin (i.e. a positive offset, Fig. 22), and a
third in which the midpoint of FITC-annexin binding narrowly preceded that of
MC540 (i.e. negative offset, Fig. 23). Each of these figures show plots of
simulations at 0, 5, 10, and 15% dead (Panels A, B, C, and D, respectively). The
simulated data allowed me to distinguish two aspects of the residual shape: the
change in shape due simply to the progression into apoptosis (seen in the
transition from a residual symmetric about the x axis in Fig. 21A to a tilted but still
symmetrical shape in Fig. 21D) and the irregularity due to temporal offset
between the binding of the two probes. The simulated data revealed that positive
versus negative offset produced two different patterns of residuals. In the
positive offset condition (Fig. 22), the residual pattern showed a prominent rightskewed peak above the x-axis. The pattern in the negative offset condition
appeared, predictably, to be the mirror image of the positive offset, with the line
of symmetry running from the origin to the upper right corner of the graph (e.g.
compare Fig. 22D to Fig. 23D). In comparing simulated to actual data, it became
clear that the residual patterns in actual data more closely resembled the
simulated data with a positive offset (exemplified in Fig. 24, which displays Fig.
20B and Fig. 22B side by side for easier comparison). This suggested that
MC540 binding precedes PS exposure by a narrow but consistent window in dextreated cells.
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Dibutyryl-cAMP treatment
Assays of PI fluorescence, MC540 spectroscopy, and MC540 and FITC-annexin
flow cytometry were repeated in cell samples treated with db-cAMP to further
assess the dependence of MC540 fluorescence changes upon PS exposure. As
shown in Fig. 25A, the MC540 ∆/∆max from spectroscopic analysis increased with
db-cAMP treatment. The parabolic shape of this response with respect to
percent dead qualitatively matched the onset of sPLA2 susceptibility (as shown in
the overlaid curves in Panel B) and the normalized mean from MC540 flow
cytometry histograms (Panel C). The MC540 histogram ratio was not a match
with the ∆/∆max, (black curve in Panel D) similar to the results from the dex
assays. Furthermore, the histogram ratio reached only about 0.4 at its highest
point. On the other hand, PS exposure measured by the histogram ratio was
very low compared to dex-treated samples, as displayed in Panel C (compare
the green curve for the db-cAMP samples with the red curve for the dexsamples). These results are complicated but suggest that lipid spacing increases
with db-cAMP treatment, that it relates temporally to susceptibility, and that it
does not require concomitant PS flip-flop.
DISCUSSION, PART II: GLUCOCORTICOID & DIBUTYRYL CAMP-INDUCED
APOPTOSIS
The results from three probes of membrane structure, laurdan, MC540, and
FITC-annexin, identified several intriguing correlations between the activity of the
enzyme sPLA2 and the physical state of the membrane. First, micrographs of
laurdan GP revealed two distinct populations that emerge as a result of
glucocorticoid stimulation: one with decreased lipid order (i.e. “mixed” in Fig. 14)
and one with increased lipid order (i.e. “red” in Fig. 14) with respect to the
healthy/untreated state (i.e. ”ring” in Fig. 14). The fact that the “mixed”
population appeared and disappeared over the course of apoptosis suggested
that it represents an intermediate state between “ring” and “red”. Even more
suggestive of an intermediate state is the fact that the fraction of “mixed” cells in
the population corresponded with the “alive & susceptible” group, a group that by
definition is transitory between “alive & resistant” and “dead”. All together, these
observations strongly suggested that the mechanisms which lead from the “ring”
to the “mixed” configuration of lipid order also lead to the transition between
resistance and susceptibility in live cells. This inference is supported by similar
observations in samples incubated with ionomycin for long time periods (4-5 h).
Laurdan GP declined immediately following ionomycin addition, and the transition
from “ring” to “mixed” was observed (e.g. the change from Fig. 7E to Fig. 7F);
after 4 h of incubation, the GP value increased above pre-treatment levels (data
not shown). While the mechanisms leading to these fluctuations in laurdan GP
require further investigation, clearly the properties which it is reporting are of
great importance in the determination of resistance versus susceptibility to the
snake venom isoform of sPLA2. Moreover, laurdan GP is directly sensitive to
penetration of the bilayer by water molecules. Experimental and theoretical data
have shown that relative hydrolytic efficiencies of App D49 sPLA2 of various
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synthetic phospholipids depend upon the access of water molecules to the active
site afforded by the configuration of the substrate-enzyme complex (84, 85),
which corroborates the correlation between increased water penetration and
onset of sPLA2 activity observed in both ionomycin- and dex-treated samples.
The analysis of assays of MC540 fluorescence also found correlations
with enzyme activity. Three parameters related to MC540 fluorescence were
assessed: changes in the proportion of higher-intensity pixels over the cell
surface (from microscopy experiments), total intensity changes (Δ/Δmax from
spectroscopy and the mean intensity from flow cytometry histograms) and
changes in the cell population with respect to MC540 fluorescence (ratios from
flow cytometry histograms).
The proportion of higher-intensity pixels was evaluated to determine
whether increased MC540 fluorescence observed via spectroscopy and flow
cytometry was due to increased probe binding or increased quantum yield of
probe molecules already bound. This evaluation was accomplished through
analysis of histograms of confocal images. The logic used to address this
question was as follows. If the rise in total MC540 fluorescence intensity (from
spectroscopy) and intensity per cell (from flow cytometry) in response to dex or
ionomycin treatment were due solely to increased probe binding, then the shape
of the distribution of pixel intensity would not change. If, on the other hand,
higher overall intensity involved increased quantum yield of bound probes, the
distribution would change so that high-intensity pixels would replace those of
lower intensity. Analysis of the histograms revealed an increase in the proportion
of pixels in the highest intensity range concomitant with a reduction in the
proportion of pixels at lower intensity values in cells treated with ionomycin (see
Fig. 18). These observations suggest that increased MC540 fluorescence
intensity is due at least in part to increased quantum yield of probes already
bound to the membrane, which is indicative of a change in the environment the
probe encounters in the membrane (i.e. from more solid to more fluid, Ref. 86).
Furthermore, visual inspection of the images suggested an increase in the
heterogeneity of pixel distribution across the membrane surface in response to
apoptotic stimulant.
A caveat to this proposed explanation is that the image resolution is not
great enough for individual probes to be resolved or to ensure that individual
pixels do not represent multiple probes. Therefore, an alternative explanation of
this observation could be that, in apoptotic membranes, the MC540 molecules
tend to aggregate together or bind preferentially to discrete sites which are very
close together, thus leading to brighter pixels in specific regions of the cell
surface. Distinction between these two possibilities would require further
experimentation, possibly using the number and brightness analysis developed
by Digman et al. (87).
Sigmoid fits of MC540 Δ/Δmax and mean intensity from histograms of
MC540 flow cytometry data were almost identical to the fit of the progression of
total percent of population susceptible to sPLA2, suggesting that both of these
measures of MC540 behavior are detecting the same properties and that those
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properties are highly relevant to sPLA2 hydrolytic activity. Furthermore, analysis
of confocal microscopy data point to a heterogeneous distribution of higherintensity pixels, suggesting that lipid spacing is not uniform throughout the
plasma membrane. This is corroborated by results with laurdan in erythrocytes
and suggests a correlation between the proliferation of boundaries between lipid
regions of differing physical properties (88). Moreover, it has been proposed
previously that sPLA2 may be most active at such boundaries (19, 88).
Heterogeneity of lipid spacing implies that alterations in the packing of lipids in
the outer leaflet are spatiotemporally regulated during the process of apoptosis.
However, the cell population changes in MC540 intensity seemed to lag behind
the total intensity changes. Fig. 16 illustrates this separation. Apparently, there
are two separate phases of membrane alterations to which MC540 is sensitive:
an initial increase in intensity in a smaller population of cells followed by shift in
the remaining population.
One possible explanation for reduced lipid packing in apoptotic cells is the
translocation of PS to the outer leaflet. In fact, MC540 binding has been used as
an assay of PS exposure in various published reports (89, 90); moreover,
previous studies have found high temporal correlation between these two
parameters in different cell types (51, 91). In order to clarify this relationship in
dex-treated S49 cells, I included flow cytometry assays in which cells were
stained with both MC540 and FITC-annexin. The results displayed in Fig. 19
showed a strong correlation between the ratios of MC540 and FITC-annexin (r2 =
0.93). However, the curves for measures of MC540 total intensity (shown in Fig.
16) clearly show relationships that correspond to total percent susceptible and
which precede the changes detected by the histogram ratios of either probe.
This suggested that the initial phase of MC540 response is independent of PS
exposure while the second phase could be linked to loss of membrane
asymmetry. That the initial phase of MC540 response is independent was
corroborated by analysis of samples labeled with both probes (Fig. 20). MC540
intensity increased slightly before FITC-annexin binding increases in individual
cells treated with dex for 2-8 h (confirmed by data simulations, see Figs. 20-24).
Furthermore, these analyses also emphasize the initial phase of MC540
response corresponded strongly with sPLA2 activity, while the second phase and
PS exposure appeared to occur too late to be causative of the initial onset of
membrane susceptibility in S49 cells.
The temporal separation between the first phase of MC540 response and
the second phase of MC540 response (that corresponds to PS exposure) implies
that the so-called second phase of MC540 response is more likely a result than a
cause of PS exposure, and the first and second phases of MC540 response may
not be related to one another. Said differently, if phase two is a continuation of
phase one, then the correlation between PS and MC540 phase two is probably
casual. If the relationship between PS and phase two is causal, then the two
phases represent independent events since phase one precedes PS exposure.
In order to further clarify this complicated relationship among lipid spacing,
PS flip flop, and sPLA2 activity, flow cytometry and spectroscopy assays of
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MC540 and FITC-annexin were repeated in cells treated with db-cAMP.
Dibutyryl cAMP was selected because previous studies reported that it induces
apoptosis in the absence of the characteristic PS exposure (9). Our results
confirmed that, indeed, PS translocation is greatly attenuated with db-cAMP
compared to dex treatment (compare green curve for db-cAMP to red curve for
dex in Fig. 25D). Spectoscopy data showed that MC540 Δ/Δmax reached levels
close to that found in dex-treated samples (compare Fig. 25A to Fig. 15B). As in
the dex data set, the ratios of MC540 and FITC from the flow cytometry
histograms were again very similar, while the histogram mean was a good
qualitative match with both the Δ/Δmax and the total percent susceptible (although
the correlations were not as strong as in the dex data set, possibly due to smaller
sample size). These experiments provide corroborating evidence suggesting
that PS exposure is not a requirement for the change in total MC540 intensity.
The qualification to this logic is that it assumes a proportional relationship
between MC540 and PS exposure. The results exemplified in Fig. 20 suggest
that MC540 fluorescence intensity precedes FITC-annexin binding in individual
cells. However, such an observation does not rule out the possibility that a small
amount of PS exposure initiates MC540 binding and/or sPLA2 activity. Since PS
exposure does not appear to be an all-or-none event (based on the steepness of
the sigmoid curve in Fig. 19C, red curve), it is impossible to exclude this
possibility. Results from cells treated with db-cAMP found a small amount of PS
exposure in a reasonable amount of cells; therefore, it is still plausible that low
levels of PS exposure facilitate relaxed lipid packing and the ensuing onset of
sPLA2 susceptibility. More detailed studies in which PS exposure is inhibited will
be required to definitely establish whether even minimal levels of PS
translocation are required for and/or permit altered lipid spacing.
It is important to compare these observations to the existing body of
knowledge regarding thymocyte apoptosis. As mentioned above, the alteration
in lipid spacing detected by MC540 simultaneous with PS exposure in apoptotic
membranes has been previously reported (89, 90). These reports relied on less
precise measures of MC540 fluorescence, both in terms of quantitative accuracy
and temporal resolution in terms of apoptotic progression in individual samples.
Moreover, I was lead to re-examine the flow cytometry results reported here
because of the discrepancy between the spectroscopic analysis and the
histogram ratio data; the combination of spectroscopy, microscopy, and flow
cytometry was essential in recognizing that multiple processes appear to be
contributing distinguishably to detectable changes in MC540 fluorescence
behavior. This report thus represents a novel finding with respect to two phases
of MC540 response and the temporal delay between MC540 initial response and
the bulk of PS exposure during dex-stimulated apoptosis. However, it is
essential to note that the observations described herein may be wholly
dependent upon the apoptotic stimulant, as the order of specific apoptotic events
has been found to be variable dependent upon the treatment applied (described
further below), and caution must be employed in interpreting these results as
contradictory to earlier findings.
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How do these reported changes in laurdan, MC540, FITC-annexin, and
sPLA2 activity correspond to the timing of other apoptotic hallmarks? Nielson et
al. found loss of mitochondrial membrane potential to be a late apoptotic event in
dex-treated S49 cells, preceded by sPLA2 susceptibility, early DNA
fragmentation, and PS exposure (9), suggesting that alterations leading to sPLA2
susceptibility are independent of both mitochondrial signaling and the
downstream caspase activation. Since the changes I observed with MC540 and
laurdan GP correlated with sPLA2 susceptibility onset, it is likely that the
mechanisms that lead to membrane alterations are likewise independent of
mitochondrial signaling. Such independence is supported by experiments with
an inhibitor of caspase 3 (an effector caspase), which reported that MC540 and
FITC-annexin labeling were both independent of caspase activation in murine
splenocytes (92). Preliminary experiments in the Bell lab have also found that a
general caspase inhibitor does not attenuate the apoptotic response in
ionophore-treated S49 cells (not shown). Moreover, detection of membrane
unpacking by MC540 has also been reported to precede DNA cleavage in B
cells, T cells, and thymocytes treated with cycloheximide (70).
On the other hand, some studies have shown disruption of mitochondrial
integrity to be essential to glucocorticoid-induced cell death (93-96). Still others
have found that the so-called non-genomic effects of glucocorticoid signal
transduction include translocation of the activated glucocorticoid receptor directly
to the mitochondria (97). These disparate findings highlight the ongoing
controversy regarding the mechanisms of glucocorticoid-induced apoptosis, the
timing of apoptotic events in response to glucocorticoids, and the role of
mitochondrial proteins and their supposed downstream targets, caspases (38).
Moreover, these discrepancies also reflect the growing understanding that the
sequence and interrelation of apoptotic events is dependent upon both cell type
and method of apoptotic induction. For example, in murine lymphoid cells, order
of apoptotic events and dependence upon caspase activation were reported to
be specific to the cell type and apoptotic stimulant (92). In S49.1 cells stimulated
with gamma ray irradiation, MC540 and FITC-annexin binding occurred
simultaneously, followed shortly by appearance of hypodiploid nuclei, then loss of
membrane integrity, and finally fragmentation of DNA. Other studies have also
found that PS exposure and DNA fragmentation (which is generally the result of
caspase activation of endonucleases, (98, 99) are independent of one another in
Jurkat T cells and HL-60 monocytic cells (100). The observations presented
here do not appear to be relevant to signals transduced via mitochondrial
pathways involving caspase activation. Experiments with caspase inhibitors are
currently underway in the Bell lab to confirm whether the changes in membrane
biophysical properties induced by both ionophore and dex are dependent upon
caspase activity (mentioned above).
This raises the obvious question, then, of what the mechanistic links could
be between dex signaling and membrane changes which render the membrane
susceptible if not mitochondrial signal transduction. Other possible candidates
include cytoskeletal alteraltions, changes in raft clustering or distribution, and
variations in lipid and protein content of the membrane. While none of these
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candidates was assessed directly in this portion of the study, existing reports
allow plausible inferences to be made. As described in Part I, the cytoskeleton
appears to play an important role in certain forms of apoptosis. For example, it is
essential to fas-mediated apoptosis (61). Cytoskeletal rearrangement or
disruption could certainly affect membrane rigidity and could also be linked to raft
redistribution. The heterogeneity of MC540 fluorescence intensity detected by
confocal microscopy suggests uneven distribution of lipid properties that is often
associated with rafts. The relationship between MC540 binding and raft
dynamics is unclear since cholesterol depletion does increase the interaction of
MC540 with the membrane surface in erythrocytes (51). The role of cholesterol
in the membrane properties assessed here requires further investigation and is
difficult to undertake in nucleated cells since cholesterol depletion assays almost
surely have confounding effects on cell homeostasis. Furthermore, although
snake venom sPLA2 activity has not been shown to correspond to availability of a
preferred lipid substrate (31), change in content of lipids and proteins in
membrane could facilitate the altered lipid spacing and hydration reported here,
thus leading to increased access of lipid monomers and the nucleophilic reactant
(water) to the enzyme’s active site. Therefore, while such possibilities require
further examination, these new observations provide intriguing evidence that
increased sPLA2 susceptibility corresponds temporally to specific biophysical
alterations, including increased lipid spacing and altered membrane hydration.
CONCLUSION
The long-term goal of this line of research is an understanding of the relationship
between cell membrane structure and the differential activity of sPLA 2 in
physiological settings. To that end, this report applies the model of sPLA2 action
developed by multiple researchers (see Scheme 1) to nucleated cells to test
hypotheses derived from erythrocyte studies. Erythrocytes were employed in
those prior studies because they offer a simplified, quasi-cellular model devoid of
certain experimental complications such as probes binding to intracellular
membranes. Fortunately, these complications were addressed here using flow
cytometry, confocal microscopy, and two-photon microscopy to assist in the
interpretation of the data. The move to lymphocytes was a meaningful step
towards a biologically relevant system in which susceptibility to sPLA 2 occurs
during physiological processes including apoptosis. Moreover, the inclusion of
glucocorticoid-stimulated cell cultures, a system which mimics an endogenous
process of apoptosis induction, represents the culmination of much foundational
work in artificial and simplified biological membranes. Most importantly, this
investigation demonstrated means by which biophysical techniques and
information regarding membrane-protein interactions can be applied to studies of
nucleated cells.
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FIGURE LEGENDS
SCHEME 1 Reaction scheme for interaction between sPLA2 and cell
membranes. E, free sPLA2; EB, sPLA2 adsorbed to membrane surface sites (Ms);
S, available substrate (membrane phospholipid); EBs, adsorbed enzyme with
substrate bound to the active site; KA, equilibrium constant for enzyme adsorption
to the membrane; KE, equilibrium constant for substrate migration into the
enzyme active site; kcat, turnover number for substrate hydrolysis; P, product
(fatty acid).
FIGURE 1 Effects of ionomycin treatment on the time course of membrane
hydrolysis by sPLA2. S49 cells were incubated with ADIFAB and treated for at
least 600 s with DMSO (curve a) or ionomycin (curve b) as explained in Materials
and Methods. At the time indicated by the arrows, sPLA2 (70 nM final) was
added. Data points represent the raw data (expressed in GP units), and curves
represent nonlinear regression fits of the data using an arbitrary function
consisting of the sum of two exponential functions. The amount of hydrolysis
observed in curve a constitutes approximately 2–5% of the plasma membrane
phospholipid (18).
FIGURE 2 Secretory PLA2 concentration dependence of the initial rate of
hydrolysis. Panel A: the experiments of Fig. 1 were repeated at the indicated
concentrations of sPLA2 for cells treated with DMSO (squares) or ionomycin
(triangles). The initial rate was defined as the amount of product generated
during 5 s from the time of enzyme addition. This number was calculated from
nonlinear regression fits of the data as shown in Fig. 1. Data were analyzed by
two-way analysis of variance to assess the contribution of sPLA2 concentration
(37% of variation, p < 0.0001), ionomycin treatment (13% of variation, p <
0.0001), and the interaction between the two (20% of variation, p < 0.0001).
Data points represent the raw data (expressed in GP units), and curves
represent nonlinear regression fits of the data using an arbitrary function. Panel
B: the total amount of product after 600 s (or at the maximum for time courses
shaped like that of curve a in Fig. 1) for enzyme concentrations ≥18 nM. The data
were significant based on two-tailed unpaired Student’s t test (p < 0.0001, n = 1–
4 at each datum).
FIGURE 3 Reversibility of adsorption of L-PLA2 to S49 cells. Data represent
histograms for Oregon Green fluorescence intensity obtained by flow cytometry
as explained in Materials and Methods. Panels A and B: Cells were treated with
DMSO (A) or ionomycin (B) for 5 min followed by 5 min incubation with 1 µM LPLA2. Samples were then transferred immediately to the flow cytometer. Panels
C and D: The experiments of Panels A (C) and B (D) were repeated as stated
except that cells were separated from the supernatant by centrifugation and
washed in fresh MBSS with 20 mM BaCl2 prior to flow cytometry. In Panels B
and D, the left arrow indicates the low intensity, reversible staining of cells with LPLA2, and the right arrow indicates the high intensity staining that was not
removed by washing (explained in Results).
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FIGURE 4 Concentration dependence of L-PLA2 adsorption to S49 cells. Panel
A: The experiments of Figs. 3A and B were repeated at the indicated
concentrations of L-PLA2. The amount of adsorbed L-PLA2 was estimated from
the fluorescence intensity represented by the mode of the low-intensity peak in
the flow cytometry histograms (e.g. as indicated by the left arrow in Fig. 3B).
Data (squares: DMSO; triangles: ionomycin) were fit by nonlinear regression to a
standard Langmuir binding isotherm function. Panel B: values for an apparent
adsorption constant (KL) and the maximum adsorption at saturation (Amax) were
obtained from fits such as those shown in Panel A for four independent
experiments. The data for DMSO and ionomycin-treated samples were
compared by two-tailed paired Student’s t test. Adsorption constant: p = 0.39;
maximum adsorption: p = 0.20. Data are expressed as mean ± SE.
FIGURE 5 Ability of L-PLA2 to interfere with cell membrane hydrolysis by sPLA2.
Cells were treated 400 s with ionomycin and then subjected to hydrolysis by 70
nM sPLA2. Hydrolysis was assayed using propidium iodide (see Materials and
Methods). The relative hydrolysis rate was calculated as the inverse of the halftime for uptake of propidium iodide by the cells (16). The experiment was
repeated in the presence of the indicated concentrations of L-PLA2. The data
were fit by nonlinear regression to Eq. 1 as described in Results.
FIGURE 6 Effects of ionomycin treatment on MC540 fluorescence. Panel A:
Representative emission spectra showing the intensity of MC540 bound to S49
cells before (solid curve, labeling details explained in Materials and Methods) and
10 min after ionomycin addition (dashed curve). Panel B: Spectra displayed in
panel A were normalized to their respective maximum intensities. The change in
MC540 fluorescence intensity (Panel C, quantified as described in Materials and
Methods) and shift in wavelength of emission maximum (Panel D) were
compared for controls (vehicle and EDTA controls; see Materials and Methods)
and ionomycin-treated samples by two-tailed unpaired Student’s t test. Data are
expressed as mean ± SE. Panel C: p < 0.0001; Panel D: p = 0.005; n = 6
(Controls) or n = 3 (Ionomycin).
FIGURE 7 Effect of ionomycin on laurdan GP. Panel A: Cells labeled with
laurdan were treated without (curve a, vehicle control) or with ionomycin (curve
b) at the arrows. 30 points prior to arrow were averaged for each experiment and
pooled in the “Before Treatment” group (n = 12) in Panel B. “Controls” (n = 6)
and “Ionomycin” (n = 6) groups represent the average of 30 points after
stabilization of the fluorescence signal. Data are expressed as mean ± SE and
analyzed by one-way analysis of variance with Bonferroni’s Multiple Comparison
Post Test (p < 0.0001 overall; Before Treatment compared to Controls: p > 0.05;
Before Treatment compared to Ionomycin: p < 0.001; Controls compared to
Ionomycin: p < 0.001). Panels C–F: Two-photon images of S49 cells were
collected before and after incubation with ionomycin in the absence or presence
of EDTA (as a control). In each image, the left half displays a broad range of GP
values from –0.1 (white) to 0.62 (dark gray), and the right half displays the same
image with a basement threshold of 0.1 so that only pixels corresponding to high

41

GP values are shown. Panel C: EDTA, Panel D: EDTA + ionomycin, Panel E:
normal calcium, panel F: normal calcium + ionomycin.
FIGURE 8 Effect of ionomycin on bis-pyrene and DPH fluorescence. Panel A:
Time course of bis-pyrene excimer-to-monomer ratio; ionomycin was added at
the arrow. Panel B: Cells were labeled with DPH as explained in Materials and
Methods, and anisotropy measurements obtained before (n=10, all samples
pooled) and after treatment with control reagent(s) (n=6) or ionomycin (n=4).
Data are expressed as mean ± SE and were not significant based on one-way
analysis of variance (p = 0.61).
FIGURE 9 Effect of ionomycin on the rate of NBD-PC extraction by BSA. Panel
A: time course of NBD-PC fluorescence in samples treated with ionomycin (gray)
or control reagent(s) (black) with t=0 corresponding to the time of BSA addition.
Data points are normalized to the maximum and minimum fluorescence intensity,
and curves are two-phase exponential decay fits. Panel B: The rate constant
obtained from these fits for controls (n=7) and ionomycin-treated (n=5) samples
were compared by two-tailed unpaired Student’s t test. Data are expressed as
mean ± SE (p = 0.003). Panels C–E: Two photon images of an S49 cell labeled
with NBD-PC and treated with ionomycin before (C), 2 min after (D), and 4 min
after (E) addition of BSA.
FIGURE 10 Effect of actin disruption on susceptibility to sPLA2 hydrolytic
activity. Cells were treated with cytochalasin D as explained in Materials and
Methods, and values presented were obtained from analysis of PI time courses
as described (see Materials and Methods and Results, Part II, “Time course of
sPLA2 susceptibility”). White Columns (graphed on left axis): “% Alive &
Susceptible” values were calculated in samples treated with cytochalasin D or
DMSO (Control). Columns analyzed by two-tailed paired Student’s t test (p =
0.34, n = 9). Gray columns (graphed on right axis): half time values were
calculated as 50% of the time to reach maximal fluorescence from baseline
fluorescence upon addition of ionomycin in the presence of sPLA2. Columns
analyzed by two-tailed paired Student’s t test (p = 0.55, n = 9).
FIGURE 11 Analysis of hydrolysis results in terms of Scheme 1. Initial sPLA2
hydrolysis rates from Fig. 2A were fit by nonlinear regression to Eq. 2 multiple
times with various combinations of constraints. Panel A: baseline parameter
values were obtained by fitting the control (DMSO) data from Fig. 2A; parameter
values are listed in the first row of Table 1. Some parameters were allowed to
float in fits of the ionomycin data (Panels B–F) as detailed below. ST was fixed at
1.0 GP units in Panel A and at 4.66 GP units with the ionomycin data (except in
Panel C) as explained in the text. The remaining parameters were kept fixed at
the values obtained in Panel A (details in rows 2–6 of Table 1). The parameters
allowed to float during the fits for each panel were: Panel B: none, Panel C: ST,
Panel D: KE, Panel E: KA, Panel F: KE and KA.
FIGURE 12 Onset and progression of dex-stimulated susceptibility to sPLA2
hydrolysis. Panel A: Representative time course of propidium iodide
fluorescence. Cells were incubated with dex for 24 h. Propidium iodide added at

42

arrow 1, sPLA2 added at arrow 2, and ionomycin added at arrow 3. Three cell
populations were quantified from these time courses: cells that were already
dead and thus susceptible (increase from a to b, due to immediate uptake of PI);
cells that were alive and susceptible (increase from b to c, due to additional
uptake upon sPLA2 hydrolysis); and cells that were alive and resistant to sPLA2
activity (increase from c to d, due to ionomycin treatment). In each case the
changes in fluorescence in these intervals was compared to the total
fluorescence increase (increase from a to d) after ionomycin addition. See
Materials and Methods for further explanation. Panel B: Total percentage of cell
population susceptible to hydrolysis by sPLA2 as a function of percent dead in
each sample, measured by trypan blue uptake. Data points were fit to a variable
slope sigmoid function with bottom and top fixed at 0 and 100. See Table 3 for
relevant fit parameters.
FIGURE 13 Effect of dex treatment on the rate of NBD-PC extraction by BSA.
Extraction experiments were carried out in cell samples treated with dex or
DMSO as described in Fig. 9 and exemplified in Fig. 9A. Rate constants
obtained from fitting time courses to 1-phase exponential decay function by
nonlinear regression, with t=0 at BSA addition. Normalized change in rate
constant was calculated for each matched treatment-control pair by: (kdexkDMSO)/kDMSO. These values were plotted as a function of percent dead in dex
sample.
FIGURE 14 The complex progression of the pattern of laurdan GP over cell
surface in response to dex treatment. Cells were incubated with DMSO for 24 h
(Panel A) or with dex for 6 h (Panel B), 24 h (Panel C), or 48 h (Panel D) were
labeled with laurdan, and images of laurdan GP were obtained by two-photon
excitation microscopy. Cells were classified into three categories: “ring” (e.g. cell
1), “mixed” (e.g. cell 2), or “red” (e.g. cell 3). Panel E: Fraction of population in
each category (“red” in red, “ring” in black, and “mixed” in blue) as a function of
percent dead. 20 random images were obtained from each of the 25 cell
samples included. “Red” and “ring” data points were fit to a variable slope
sigmoid function (red and black curves, respectively). Midpoints from sigmoid fits
with 95% confidence intervals: 57.64% dead ± 13.77% (red); 56.43% dead ±
16.19% (ring). Panel F: Data points for the “mixed” fraction from Panel E (blue,
plotted on left y axis) with the percent of cells alive and susceptible to the
enzyme (from assays of PI fluorescence described in Materials and Methods and
the legend to Fig. 12; gray, plotted on right y axis). Corresponding curves
represent Gaussian fits of the data points.
FIGURE 15 Effect of dex treatment on MC540 fluorescence intensity measured
by spectroscopy. Panel A: Normalized emission spectra of MC540 bound to cells
after 24 h treatment with control solvent (dashed black), 24 h treatment with dex
(solid black), and after incubation with ionomycin (red). Ionomycin treatment
induces a maximal response in terms of increased MC540 fluorescence
emission; therefore, spectra were collected for each sample before and after
ionomycin treatment in order to compare each sample to its respective maximum
possible response. Panel B: Percent Δ/Δmax MC540 response is plotted as a
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function of percent dead. The y axis was quantified as described in Materials
and Methods. Data were fit to a variable slope sigmoid function (black curve) with
bottom and top fixed at 0 and 100. See Table 3 for relevant fit parameters. Blue
dashed curve is an overlay of the fit from Fig. 12B to compare MC540
fluorescence changes to total percentage of cell population susceptible to
hydrolysis by sPLA2.
FIGURE 16 Effect of dex treatment on MC540 fluorescence intensity measured
by flow cytometry. Mean intensities (Panel A) and normalized ratios (Panel B) of
flow cytometry histograms of MC540 fluorescence intensity (from histograms
exemplified in Fig. 18A) versus percent dead. Data were fit to a variable slope
sigmoid function (black and red curve, respectively) with bottom and top fixed at
0 and 100 (Panel A) or 0 and 1.0 (Panel B). Panel C provides an overlay of the
fits from Panels A and B along with the fit from Fig. 12B (blue dashed curve) to
compare MC540 fluorescence changes to total percentage of cell population
susceptible to hydrolysis by sPLA2. See Table 3 for relevant fit parameters.
FIGURE 17 Representative confocal micrographs of MC540 fluorescence
intensity. Cells incubated 12 h with dex then labeled with MC540 and imaged
before (Panel A) and 10 min after (Panel B) addition of ionomycin. Equivalent
controls with 12 DMSO before (Panel C) and after (Panel D) ionomycin.
FIGURE 18 Effect of ionomycin treatment on histograms of MC540
fluorescence intensity from confocal micrographs. Representative histograms
from one experiment are displayed. Y axis represents percentage of pixels at
each intensity value, calculated as described (see Materials and Methods).
Histograms were calculated for images taken before (red squares) and 5-10 min
after ionomycin addition (gray triangles). Each histogram includes pixels from
multiple images captured before and after addition of ionophore. Data were fit by
nonlinear regression to an arbitrary function (overlaid black curves). Arrows
approximately indicate x values used to calculate ratios for statistical comparison
as detailed in Results, Part II.
FIGURE 19 Correlation between dex-stimulated changes in MC540 and FITCannexin fluorescence measured by flow cytometry. Panels A and B:
Representative histograms of MC540 (Panel A) or FITC-annexin fluorescence
(Panel B) in control samples (24 h DMSO, grey curves), 24 h dex samples (solid
curves; black, MC540; red, FITC-annexin), and 48 h dex samples (dashed
curves; black, MC540; red, FITC-annexin). Regions indicated by brackets and
numbers represent the response peak (region 2 in Panel A, regions 2 and 3 in
Panel B) and the background peak (region 1 in both panels) used to calculate the
cell ratio described in Results, Part II. Panel C: Normalized ratios of histograms
for MC540 (black) and FITC-annexin (red) as a function of percent dead. Ratios
were quantified as described in Results, Part II, “Phospholipid spacing”. Data
were fit to a variable slope sigmoid function with bottom and top fixed at 0 and 1.
See Table 3 for relevant fit parameters. Blue dashed curve is an overlay of the fit
from Fig. 12B to compare ratios to total percentage of cell population susceptible
to hydrolysis by sPLA2.
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FIGURE 20 Example two-dimensional histogram of MC540 and FITC-annexin
intensity measured simultaneously by flow cytometry. Panel A: MC540
fluorescence intensity as a function of FITC-annexin intensity per cell from an 8 h
dex-treated sample labeled with both probes. Line represents linear regression.
Panel B: Residual plot of the linear regression from Panel A.
FIGURE 21 Residual plots from linear regression of simulated data with no
offset between MC540 and FITC-annexin binding. Simulations were run at
different points along the apoptotic sigmoid progression: 0% dead (Panel A, i.e.
control), 5% dead (Panel B), 10% dead (Panel C), and 15% dead (Panel D).
FIGURE 22 Residual plots from linear regression of simulated data with a 3%
positive offset between MC540 and FITC-annexin binding. 3% positive offset
refers to the midpoint of the sigmoid function being set at 17% for MC540 and
20% for FITC-annexin. Simulations were run at different points along the
apoptotic sigmoid progression: 0% dead (Panel A, i.e. control), 5% dead (Panel
B), 10% dead (Panel C), and 15% dead (Panel D).
FIGURE 23 Residual plots from linear regression of simulated data with a 3%
negative offset between MC540 and FITC-annexin binding. 3% negative offset
refers to the midpoint of the sigmoid function being set at 23% for MC540 and
20% for FITC-annexin. Simulations were run at different points along the
apoptotic sigmoid progression: 0% dead (Panel A, i.e. control), 5% dead (Panel
B), 10% dead (Panel C), and 15% dead (Panel D).
FIGURE 24 Comparison of residual plots from actual and simulated data.
Panel A: Same as Fig. 20A. Panel B: Same as Fig. 22B.
FIGURE 25 Effect of db-cAMP on sPLA2 susceptibility, MC540 fluorescence
intensity, and FITC-annexin binding. Panel A: Percent Δ/Δmax MC540 response
is plotted as a function of percent dead. For explanation of how this was
calculated, see the legend to Fig. 15 and Materials and Methods. Data points
were fit to an arbitrary function (one-site binding hyperbola, Kd = 6.04% ± 5.90%).
Panel B: Total percent susceptible is plotted on the left y axis. Data points were
fit to an arbitrary function (one-site binding hyperbola, blue curve, Kd = 16.8% ±
32.59%). Black curve is an overlay of the curve from Panel A (graphed on the
right y axis). Panel C: Normalized means of MC540 histograms from flow
cytometry data as a function of percent dead. Panel D: Normalized ratios of flow
cytometry histograms for both MC540 (black) and FITC-annexin (green) were fit
to a variable slope sigmoid function with bottom fixed at 0. Red curve is an
overlay of the curve from Fig. 18C (except that the top was not fixed at 1.0),
illustrating the level of PS exposure in dex-treated samples as a comparison.
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TABLE 1 Parameter values for Fig. 11
Parameters
β
(GP units s-1)

KA
(nM-1)

KE

ST
(relative units)

A

1.0

0.067

0.10

1.0

B

1.0

0.067

0.10

4.43

C

1.0

0.067

0.10

8.12

D

1.0

0.067

0.18

4.43

E

1.0

0.273

0.10

4.43

F

1.0

0.056

0.20

4.43

Fig. 10 Panel

Parameter values were obtained by nonlinear regression using Eq. 2 as
explained in the legend to Fig. 11. Values allowed to float in the regression are
underscored.
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TABLE 2 Categories of dex-treated cells by laurdan GP
Category

Whole cell
GP range

Interior
GP range

Exterior
GP range

Ring

0.08-0.18

0.02-0.10

0.10-0.25

Mixed

0.18-0.30

0.18-0.30

0.18-0.30

Red

>0.35

>0.35

>0.35

Pixels isolated to calculate interior GP represented approximately 70% of whole
cell pixels in each case. Ranges are approximate; categorization was confirmed
by visual analysis. Analysis performed using SimFCS software provided by the
Laboratory for Fluorescence Dynamics (University of California, Irvine). Exterior
GP calculated by: (whole cell GP x whole cell pixels – interior GP x interior
pixels)/exterior pixels.
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TABLE 3 Midpoints with 95% confidence intervals for sigmoid fits in Figs. 12,
15, 16, and 18
Parameters
Measurement

Midpoint
(% dead)

C.I. lower
limit

C.I. upper
limit

Total % susceptible

45.42

42.30

48.54

MC540 Δ/Δmax

46.98

40.45

53.51

MC540 histogram mean

44.41

38.97

49.86

MC540 histogram ratio

64.19

58.80

69.58

FITC-annexin histogram ratio

60.41

55.61

65.21

Parameter values were obtained by nonlinear regression as explained in the
legends to Figs. 12, 15, 16, and 18.
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Intern/Translator – Galapagos Islands, Ecuador
May 2006
Translated English-Spanish for Dr. Nikole Clark, an American family practice
physician, in a medical outreach clinic in Santa Cruz; admitted patients to clinic
and assisted with medical records; taught one -on-one dental hygiene lessons to
children under 12.
Brigham Young University, Center for Service & Learning
Volunteer Tutor – Organic Chemistry, Human Anatomy
2005-2006
Conducted biweekly tutoring sessions with 1 -2 undergraduates per semester;
taught organization, reading, note-taking, and study skills.
Benson Institute
Public Health Intern – La Paz, Bolivia Office
Apr-Jun 2004
Taught nutrition classes in Spanish to 15 mothers as well as hygiene classes to
30 elementary students in rural schools; conducted a breastfeeding workshop for
mothers in a nearby village; collaborated with other American interns and
University students from La Paz.
Assisted in conducting a 6-month follow-up survey of 3 villages following the
installation of water pumps by a local NGO; helped insta ll and maintain small
greenhouses at local schools to improve child nutrition through increased intake
of fresh vegetables.
Church of Jesus Christ of Latter-day Saints
Volunteer – Provo Area
2002-2008
Holds/held various ecclesiastical callings in lo cal congregation including
counselor in presidency of the Children’s Primary, activities director, and choir
director.
SKILLS & CERTIFICATIONS


Proficiency in spoken and written Spanish.



College Reading and Learning Association, certified level 1 tutor.



Proficient in SAS, Excel, Prism GraphPad graphing and statistical software,
and QUICK BASIC.

